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Abstract: Glycomacrolactones exhibit many interesting biological properties, and they are also
important in molecular recognitions and for supramolecular chemistry. Therefore, it is important to
be able to access glycomacrocycles with different sizes and functionality. A new series of carbohydrate-
based macrocycles containing triazole and lactone moieties have been designed and synthesized. The
synthesis features an intramolecular nucleophilic substitution reaction for the macrocyclization step.
In this article, the effect of some common sulfonate leaving groups is evaluated for macrolactonization.
Using tosylate gave good selectivity for monolactonization products with good yields. Fourteen
different macrocycles have been synthesized and characterized, of which eleven macrocycles are
from cyclization of the C1 to C6 positions of N-acetyl D-glucosamine derivatives and three others
from C2 to C6 cyclization of functionalized D-glucosamine derivatives. These novel macrolactones
have unique structures and demonstrate interesting anion binding properties, especially for chloride.
The macrocycles containing two triazoles form complexes with copper sulfate, and they are effective
ligands for copper sulfate mediated azide-alkyne cycloaddition reactions (CuAAC). In addition,
several macrocycles show some selectivity for different alkynes.
Keywords: glycomacrocycles; glucosamine; macrolactonization; click chemistry; triazole; copper
catalyst; anion binding
1. Introduction
Macrocyclic compounds are important classes of molecules with many biological ap-
plications and useful for drug discovery [1,2]. Carbohydrate-based macrocyclic compounds
have unique molecular architectures and many practical applications [3,4]. Naturally exist-
ing and synthetic carbohydrate-based macrocycles have been utilized in drug discovery,
molecular recognition, and as advanced functional materials [1,3,5–7]. Among the different
classes of macrocycles, macrolactones are especially unique compounds that exhibit biolog-
ical activities and often function as enzyme inhibitors; they also showed applications in
molecular recognition for supramolecular chemistry. For example, macrolactones synthe-
sized from cholesterol derivatives have shown utility for molecular recognitions [8], and a
synthetic macrodilactone exhibited enantioselective recognition of amino alcohols, as well
as metal ions [9]. Naturally existing carbohydrate-based macrolactones or macrolides often
exhibit many desirable biological activities for drug development [10–12]. The structures
of several macrolactones are shown in Figure 1. Erythromycin (1) is a sugar-containing
macrolide antibiotic. Ipomoeassina F (2) and analogs are macrolactones containing a dis-
accharide unit, which exhibit anticancer activities and recently have been identified as
protein-translocation inhibitors [5,13]. Glucolipsin A (3) and analogs are natural products
containing sugar dilactones—they are inhibitors for dual specific phosphatase Cdc25A [14].
This compound was synthesized from the corresponding hydroxy acids through a macrodi-
lactonization reaction mediated by 2-chloro-1,3-dimethylimidazolinium chloride.
Using a hexapyranose as the scaffold, a variety of synthetic macrolactones can be
prepared depending on the cyclization patterns from different positions of the sugar
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ring. The lactonization could be introduced at an earlier stage and a different method
for the macrocyclization utilized later [12,15]. For instance, the glycomacrolactones with
azobenzene functionality have been synthesized through the cyclization from the C-2 to C-3
or C-4 to C-6 positions of D-glucose and D-mannose derivatives. These glycomacrolactones
have exhibited applications in supramolecular chemistry for the design of chemosensors
and other functional molecular assemblies [16,17]. A macrocyclic sialyl Lewis X (SLeX)
mimic synthesized by lactonization via Mitsunobu reaction from the C-1 to C-6 position
of the L-galactoside, was 1000 fold more potent for the inhibition of P-selectin than the
tetrasaccharide SLeX [18].
Triazole-based macrocyclic frameworks are important structural features in many
bioactive compounds and pharmaceuticals [19–21]. Using Cu (I) catalyzed azide-alkyne
cycloaddition reactions (CuAAC), the “click chemistry”, many classes of 1,4-disubstituted
1,2,3-triazole derivatives have been synthesized and studied. There are also many stud-
ies towards the effective transformation of [3+2] azide-alkyne cycloaddition reactions,
and triazole functions have been used as ligands for catalysis, including the CuAAC
reactions [22–26]. Besides being medicinally important, the macrocycles containing the
1,2,3-triazole moieties are also useful in forming host-guest complexes and recognitions for
ions [27–30]. The 1,2,3-triazole functional groups can act as Lewis bases to coordinate with
metal cations, and the triazoles can also recognize halides through the triazole C-H—anion
hydrogen bonds [30,31]. Triazole-containing macrocycles have shown interesting binding
properties for both anions and cations; some of them are also ditopic ion-pair receptors,
typically with rigid aromatic structures [31].
The synthesis of triazole-containing glycomacrocycles can be accomplished by many
different methods. Using click chemistry, several series of glycomacrocycles have been
synthesized and analyzed [32–34]. Several sugar-based bistriazole-containing macrocycles
(4) were synthesized, and they are effective ligands in accelerating the CuSO4 mediated
azide-alkyne cycloaddition (AAC) reactions [35]. The macrocycles with different ring sizes
showed different selectivity and catalytic effect for 1-octyne and phenylacetylene. Because
of the importance and potential applications of triazole-based glycomacrocycles, in this
study, we designed and synthesized two series of macrolactones with the general structures
5A and 5B, as shown in Figure 1.




Figure 1. Structures of several carbohydrate-based macrocycles. 
These compounds contain either one or two triazole moieties and are expected to 
have properties in binding to guest molecules or ions, resulting in useful structures and 
applications.  
2. Results and Discussion 
As shown in Scheme 1, the macrolactones with general structures 5A can be synthe-
sized starting from the intermediate 3S, which was prepared from N-acetyl-D-glucosa-
mine (NAG) [35]. By installing a suitable leaving group at the C-6 position and a nucleo-
phile, such as a long-chain and triazole-containing carboxylate linked to the anomeric cen-
ter, an intramolecular SN2 reaction of the carboxylate with the leaving group is expected 
to form the macrolactones. The carboxylate intermediate can be prepared using click 
chemistry to include one or two triazole functional groups.  
To test the feasibility of this route to synthesize the glycomacrolactones, several dif-
ferent sulfonate leaving groups towards the macrocyclization were evaluated to obtain 
suitable conditions for the cyclization reactions. Common aryl sulfonyl chlorides were se-
lected for the derivatiazation of the C-6-primary hydroxyl group of S3—these include p-
bromobenzene-, p-chlorobenzene-, p-tolyl-, and 1-naphthyl-sulfonyl chloride. Me-
thanesulfonyl chloride was not selected, since it typically reacts with both the C-4 and C-
6 hydroxyl groups readily [36]. The C-6 primary hydroxyl group of S3 was then converted 
to different sulfonate leaving groups selectively to afford 6a–6d. The intermediates 6a–6c 
were treated with benzoyl chloride to afford the corresponding dibenzoates 7, with both 
the C-3 and C-4 positions benzoylated. However, the naphthyl derivative 6d afforded 
mainly the C-3 monobenzoylation product, presumably due to steric hindrance.  
The 4-bromobenzenesulfonate 6a was converted to the corresponding dibenzoate 7a 
followed by a click reaction to afford the intermediate 8a. The intramolecular macrolac-
tonization reaction led to the monomeric lactone LM28 in 72% yield, together with 20% 
dimeric lactonization product DLM28. The 4-chlorosulfonate 6b was converted to chlo-
ride during the benzoylation step to afford the chloride 7b. Using a similar protocol, com-
pound 7b was converted the LM28 in 67% yield together with 17% DLM28; and the to-
sylate 8c led to 82% LM28 and no dimer was isolated. Based on these, the tosyl group was 
superior to other leaving groups, and this was selected to synthesize a series of other mac-
rocycles containing monotriazole and bis-triazoles (Schemes 2 and 3).  
Figure 1. Structures of several arbohydrat -based macrocycle .
n. m = 1, 2 
N,N 
X = fN~ or fCH2t 
4 m, n =1, 2 




HO : 0 H ~ 
OH ''10 I 
Glucolipsin A 
3 
Molecules 2021, 26, 3394 3 of 26
These compounds contain either one or two triazole moieties and are expected to
have properties in binding to guest molecules or ions, resulting in useful structures and
applications.
2. Results and Discussion
As shown in Scheme 1, the macrolactones with general structures 5A can be synthe-
sized starting from the intermediate 3S, which was prepared from N-acetyl-D-glucosamine
(NAG) [35]. By installing a suitable leaving group at the C-6 position and a nucleophile,
such as a long-chain and triazole-containing carboxylate linked to the anomeric center, an
intramolecular SN2 reaction of the carboxylate with the leaving group is expected to form
the macrolactones. The carboxylate intermediate can be prepared using click chemistry to
include one or two triazole functional groups.
To test the feasibility of this route to synthesize the glycomacrolactones, several dif-
ferent sulfonate leaving groups towards the macrocyclization were evaluated to obtain
suitable conditions for the cyclization reactions. Common aryl sulfonyl chlorides were
selected for the derivatiazation of the C-6-primary hydroxyl group of S3—these include
p-bromobenzene-, p-chlorobenzene-, p-tolyl-, and 1-naphthyl-sulfonyl chloride. Methane-
sulfonyl chloride was not selected, since it typically reacts with both the C-4 and C-6
hydroxyl groups readily [36]. The C-6 primary hydroxyl group of S3 was then converted
to different sulfonate leaving groups selectively to afford 6a–6d. The intermediates 6a–6c
were treated with benzoyl chloride to afford the corresponding dibenzoates 7, with both
the C-3 and C-4 positions benzoylated. However, the naphthyl derivative 6d afforded
mainly the C-3 monobenzoylation product, presumably due to steric hindrance.




Scheme 1. Macrolactonization using different sulfonates as the leaving groups. 
As shown in Scheme 2, treating 7c and 9 [35] with different alkynoic acids 10a-c uti-
lizing click reaction gave the carboxylic acids 11a–12c. The intramolecular SN2 reaction 
was carried out using K2CO3 as the base in DMF at 75 °C to afford monotriazole macro-
lactones 13a–13c, 14a–14c with different ring sizes in excellent yields. The synthesis of bis-
triazole-containing macrolactones is shown in Scheme 3. Using a similar method and the 
triazole-containing alkynoic acids 10d-e, the desired macrocycles 16a-d were obtained in 
78–90% yields. The concentrations of the cyclization step for both monotriazole and bis-
triazole-containing macrocycles were typically ~10 mM or 0.01 M of the reactants, which 
are not super dilute conditions; therefore, the method should be practical for possible 
large-scale synthesis. 
Besides using DMF as the solvent, for the intramolecular lactonization reaction, ace-
tonitrile was also used as the solvent; similar macrolactonization results were typically 
obtained through the reactions that required a longer time to complete. The monotriazole 
derivative LM28 was obtained in 77% yield in acetonitrile (9 mM concentration 6 h). The 
bistriazole-based macrocycles were also prepared in acetonitrile overnight to afford the 
macrocycle products in 71–78% yields. The typical concentration for cyclization for small 
scale reactions was about 4–6 mM; though the yields were slightly lower than those reac-
tions when DMF was used, the lower boiling point of acetonitrile makes it easier to re-
move during work up. In addition, in acetonitrile, no dimerization was observed, perhaps 
due to reduced nucleophilicities of the carboxylate in acetonitrile than DMF.  
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tonization reaction led to the monomeric lactone LM28 in 72% yield, together with 20%
dimeric lactonization product DLM28. The 4-chlorosulfonate 6b was converted to chloride
during the benzoylation step to afford the chloride 7b. Using a similar protocol, compound
7b was converted the LM28 in 67% yield together with 17% DLM28; and the tosylate 8c
led to 82% LM28 and no dimer was isolated. Based on these, the tosyl group was superior
to other leaving groups, and this was selected to synthesize a series of other macrocycles
containing monotriazole and bis-triazoles (Schemes 2 and 3).
As shown in Scheme 2, treating 7c and 9 [35] with different alkynoic acids 10a-c uti-
lizing click reaction gave the carboxylic acids 11a–12c. The intramolecular SN2 reaction
was carried out using K2CO3 as the base in DMF at 75 ◦C to afford monotriazole macro-
lactones 13a–13c, 14a–14c with different ring sizes in excellent yields. The synthesis of
bis-triazole-containing macrolactones is shown in Scheme 3. Using a similar method and
the triazole-containing alkynoic acids 10d-e, the desired macrocycles 16a-d were obtained
in 78–90% yields. The concentrations of the cyclization step for both monotriazole and bis-
triazole-containing macrocycles were typically ~10 mM or 0.01 M of the reactants, which
are not super dilute conditions; therefore, the method should be practical for possible
large-scale synthesis.
Besides using DMF as the solvent, for the intramolecular lactonization reaction, ace-
tonitrile was also used as the solvent; similar macrolactonization results were typically
obtained through the reactions that required a longer time to complete. The monotriazole
derivative LM28 was obtained in 77% yield in acetonitrile (9 mM concentration 6 h). The
bistriazole-based macrocycles were also prepared in acetonitrile overnight to afford the
macrocycle products in 71–78% yields. The typical concentration for cyclization for small
scale reactions was about 4–6 mM; though the yields were slightly lower than those reac-
tions when DMF was used, the lower boiling point of acetonitrile makes it easier to remove
during work up. In addition, in acetonitrile, no dimerization was observed, perhaps due to
reduced nucleophilicities of the carboxylate in acetonitrile than DMF.




Scheme 2. Synthesis of monotriazole-based macrocycles. 
  
Scheme 3. Synthesis of bis-triazole-based macrocycles. 
Using the macrolactonization method developed above, several macrocycles with the 
general structure 5B can be synthesized. As shown in Scheme 4, the azido sugar derivative 
17 [37] was converted to the key intermediate tosylate 20 in three steps. For the ben-
zoylation step of compound 19, pyridine was found to be a more effective solvent. The 
yields of the dibenzoylated products improved from 74% in DCM/pyridine to 91% in pyr-
idine. The intermediate azide 20 was treated with different alkyne-containing acids to 
generate the precursors for macrolactonizations. As a proof of principle, here, only two 
alkynyl acids 10c and 10d, were used. The intermediate 21 was converted to the monolac-
tonziation product 22 in good yield under similar conditions. Which indicated that the 
macrolactonization methods are applicable to the synthesis of glycomacrolactones of dif-
ferent positions to the C-6.  
The bistriazole derivative 23 was subjected to macrolactonization using different ba-
ses to obtain suitable conditions for monocyclization. Three different carbonate bases in 
anhydrous DMF were screened, and the results are shown in Table 1. It seems that the 
cations used can affect the ratio of the monomer versus the dimer; all conditions showed 
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triazole C-H and the amide NH signals of LM28 showed significant chemical shift changes 
upon adding halides. From 0 to 10.0 equiv of TBACl, the NH showed the most significant 
downfield shift of 0.59 ppm—this indicated strong hydrogen bonding with the chloride. 
The triazole signal also shifted downfield, with 2.0 equiv of TBACl, the Ha moved down-
field by 0.16 ppm; interestingly, this signal only shifted another 0.04 ppm when 10.0 equiv 
of chloride was added. The significant downfield change of triazole and NH signals with 
increasing amounts of chloride indicated that they were affected by forming hydrogen 
bonds with chloride and by anion-π interactions. Other protons were less affected by chlo-
ride additions and showed small upfield shifts. The anomeric proton shifted upfield by 
0.04 ppm, H3 by 0.05 ppm, and H4 by 0.10 ppm. Without chloride, the Hb, Hc, and Hd are 
multiplets centered at δ 4.73, 4.57, and 4.39 ppm, respectively, and the Hb and Hc each 
showed doublet of triplet splitting pattern (dt). However, with 10.0 equiv of TBACl, the 
Hb and Hc merged to a pseudo triplet. These changes indicated that the chloride binding 
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but did change the dihedral angles of anomeric methylene groups (Figure 2).  
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The 1H NMR spectra of LM28 with TBACl are shown in Figure 3, Figures S1 and S2.
The triazole C-H and the amide NH signals of LM28 showed significant chemical shift
changes upon adding halides. From 0 to 10.0 equiv of TBACl, the NH showed the most
significant downfield shift of 0.59 ppm—this indicated strong hydrogen bonding with the
chloride. The triazole signal also shifted downfield, with 2.0 equiv of TBACl, the Ha moved
downfield by 0.16 ppm; interestingly, this signal only shifted another 0.04 ppm when 10.0
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an upfield change of 0.03 ppm. The triazole signals showed concentration dependence.
Upon addition of one equiv of TBABr, the two triazole signals showed 0.08 ppm downfield
change; after further addition of TBABr, the triazole signals did not move (Figure S13). This
indicates that possibly one bromide is hydrogen bonding with both triazole protons, and
bromide formed stronger interactions than chloride did. TBAI did not cause significant
chemical shift changes (Figures S15–S17).
The 1H NMR spectra of the C-2 series macrocycles 22 are shown in Figure 4,
Figures S18 and S19. The triazole signal showed a small downfield (0.03 ppm) change
after adding one equiv of TBACl. From 0 to 10.0 equiv of TBACl, the amide NH showed a
larger downfield change of 0.19 ppm, the other protons from the sugar ring also showed
significant changes (Figure 4). The anomeric proton showed an upfield shift of 0.07 ppm.
The protons at C-3 and C-4 positions became more resolved into two triplets, and the
methylene Hb and Hc merged from two separate doublets to a pseudo quartet. This
indicated the chemical environment of the two protons become very similar.
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i ing properties of the macrocycles LM28, DM35 with Cu2+ were also studied
si several macrolactones and 1H NMR spectroscopy at variable temperatures. The
1H NMR spectra of DM35 and its complex with CuS 4·5H2O are shown in Figure 6 and
Figures S23–S25. In the complex, the two sharp triazole singlets at 7.70 and 7.69 ppm
disappeared or became broadened and shifted downfield to around 7.81 ppm. The triazole
signals were very broadened due to the paramagnetic properties of Cu (II) binding to
triazole [40]. Typically, protons within 0.9 nm of the Cu (II) were not observed due to fast
paramagnetic relaxation, and the protons in the outer shell between 0.9–1.7 nm from the
copper showed chemical shift changes and broad resonances [41]. The signals far away
from Cu (II) were not affected as much (Figure S23). This showed that the copper ion is in
close vicinity to the triazoles.
Molecules 2021, 26, x FOR PEER REVIEW 9 of 26 
 
 
and H4 appeared as a pseudo triplet; H4 shifted upfield by 0.05 ppm, while H3 stayed the 
same. The methylene Hc and Hd changed from a pseudo quartet to a broad singlet, indi-
cating that they have a similar chemical and the magnetic environment with 5.0–10.0 
equiv of TBACl. These shifts showed that the macrocycle can bind to chloride, and the 
binding of anions resulted in a conformational change of the macrocycle. 
 
Figure 5. The 1H NMR spectra of compound 24 with different amounts of TBACl. 
The binding properties f the macrocycles LM28, D 35 with Cu2+ were also studied 
using several macrol ctones and 1H NMR spectro copy at vari ble temperatur s. Th  1H 
NMR spectra of DM35 and its complex with CuSO4∙5H2  are shown in Figures 6 and S23–
S25. In the complex, the two s arp triazole s nglets at 7.70 nd 7.69 ppm disappeared o  
became broadened an  shifted downfield to around 7.81 ppm. The triazole signal  were 
very broade ed due to the par magnetic pr perties of Cu (II) binding to triazole [40]. 
Typically, protons within 0.9 nm of the Cu (II) were ot observed due to fast paramagnetic 
relaxation, nd the protons in he outer s ll be ween 0.9–1.7 nm from the copper showed 
chemical shift changes and broad resonances [41]. The signals far away from Cu (II) were 
not affected as much (Figure S23). This showed that the copper on is in close vicinity to 
the triazoles.  
 
Figure 6. The 1H NMR spectra of DM35 and its CuII complex with CuSO4∙5H2O in d6-DMSO. 
The 1H NMR s ectra of the copper complex with DM35 were also evaluated at dif-
ferent temperatures, from 30 to 60 °C (Figures 7, S24 and S25), the triazole signals showed 
upfield shift to a broad signal, but more defined peak at around 7.71 ppm, this is close to 
the chemical shifts of macrocycle without Cu (II), which indicates that the Cu (II) is more 
dissociated from the binding to the two triazole nitrogen atoms at elevated temperatures. 
The anomeric proton appeared broad singlet at 30 °C, at 4.79 ppm, and shifted to 4.81 to 
Figure 6. The 1H NMR spectra of DM35 and its CuII complex with CuSO4·5H2O in d6-DMSO.
The 1H NMR spectra of the copper complex ith DM35 were also evaluated at
dif erent temperatures, from 30 to 60 ◦C (Figure 7, Fig res S24 and S25), the triazole
signals showed upfield shift to a broad signal, but more efin d peak at around 7.71 ppm,
thi is close to the chemical shifts of m crocycle without Cu (II), which indicat that
the Cu (II) s m re dissociated from the binding to he two tri zole nitrogen atoms at
elevated temperatures. The anomeric proton appeared broad singlet at 30 ◦C, at 4.79 ppm,
and shifted to 4.81 to a doublet (Figure S24a). The amide NH signal shifted upfield at
higher temperature indicates that amide participates in intermolecular hydrogen bonding.
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NH and triazole signals (Figure S31). These results showed that for monotriazoles, such as
L 28, the copper ion was not bonded to the triazole as tightly as comparing to bistriazoles.
The complex of the C2 bistriazole derivative 24 with CuSO4·5H2O was also prepared and
the 1H NMR spectra showed similar trends (Figures S32–S34).
2.2. Effect of the Macrocycles as Ligands for CuAAC Reactions
Besides the binding studies, the effect of these macrocycles on CuAAC reactions was
also studied as shown in Scheme 5. Using the anomeric sugar azide 26 as the substrate, a
series of reactions were carried out with different alkynes, including the aliphatic alkyne
1-octyne, aromatic alkynes, such as phenylacetylene, 4-t-Bu-phenylacetylene, and 5-phenyl-
1-pentyne. The results are summarized in Tables 2–5 and SI Tables S1–S8, Figures S35–S42.
For phenylacetylene, when using 2.5 mol% macrocycle and copper sulfate as the
catalyst (Table 2a), at 2 h, all C1-series macrocycles (MCs), including both monotriazole
and bis-triazole derivatives, were able to accelerate the reaction to over 50% conversion
versus 15% conversion without the macrocycles. The most effective macrocycles are the
bistriazole macrocycles DM25 and DM35, which reached 100% conversion within 5 h. The
reactions in the presence of the monotriazole derivatives LM34, LM36, LM26 reached over
75% conversion at 5 h and almost completed after 9 h. When the monotriazoles (Table 2b)
were increased to 5.0 mol%, LM26 and LM34 were both effective in catalyzing the reactions,
reaching almost full conversions at 5 h. The C2 series macrocycles were not as effective as
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18 C2ML 2.5  10 20 40, 10 h  
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equiv of CuSO4, only DM34 was effective at catalyzing the reaction, reaching 93% conver-
sion at 2 h; the other macrocycles didn’t show improvement over the control experiment. 
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the presence of 2.5 mol% of DM34. Increasing the loading of MCs for LM26, LM34, and 
LM36 to 5.0 mol% did not improve the conversions (Tables 3 and S4). The experiments 
confirmed that DM34 was particularly efficient at catalyzing the click reaction of 1-octyne.  
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When using 1-octyne as the substrate, different macrocycles showed very different re-
sults. As shown in Table S3, with 2.5 mol% macrocycles, 1.2 equiv of 1-octyne and 0.1 equiv
of CuSO4, only DM34 was effective at catalyzing the reaction, reaching 93% conversion at
2 h; the other macrocycles didn’t show improvement over the control experiment. When
increasing the 1-octyne from 1.2 to 1.5 equiv, the reaction completed within 1 h in the
presence of 2.5 mol% of DM34. Increasing the loading of MCs for LM26, LM34, and LM36
to 5.0 mol% did not improve the conversions (Table 3 and Table S4). The experiments
confirmed that DM34 was particularly efficient at catalyzing the click reaction of 1-octyne.
OAc 
AcO~~O N ;co~ 3 
26 NHAc 
== R, 1.2-1.5 equiv 
1.0-2.5 mol% macrocycle 








28, R = Ph-, 
29, R = Hexyl, 
30, R = 1-Propyl-3-phenyl, 
31, R = p-t-Bu-C5H4-
Molecules 2021, 26, 3394 12 of 26
Table 3. Effect of the macrocycle on catalyzing the click reaction of 1-octyne (R = n-Hexyl).
Entry MC Code mol% MC Conversion(%) at 1 h
Conversion
(%) at 2 h
Conversion
(%) at 5 h
Isolated
Yield 29
1 None 0 11 14 20
2 LM26 5.0 8 12 25
3 LM34 5.0 16 18 28
4 LM36 5.0 12 14 23
5 DM24 2.5 27 35 46
6 DM25 2.5 12 25 57
7 DM34 2.5 100 87%
8 DM35 2.5 20 22 37
Condition: Sugar azide (1 equiv, 40.0 mg), CuSO4·5H2O (0.1 equiv, 2.7 mg), 1-octyne (1.5 equiv, 23.7 µL),
EtOH/H2O (v/v 1:1, 2.0 mL), NaAsc (0.3 equiv, 6.4 mg).
5-Phenyl-1-pentyne was found to be much more reactive in comparison to the other
alkynes screened. Several experiments were carried out to analyze the effect of the macro-
cycles with reduced copper loading. A few summarized results are shown in Table 4 and
Tables S5 and S6. Without macrocycles, at 2 h the reaction of the alkyne with 26 reached
100% (0.1 equiv of CuSO4) and 51% conversion when using 0.05 equiv copper sulfate. Fur-
ther reduction of copper to 1 mol%, at 2 h only 5% conversion was observed; however, with
added 2.5 mol% of DM35, the reaction reached 52% conversion. From these results, we
selected either 2.0 or 5.0 mol% of copper to evaluate the MC ligands. As shown in Table 4,
1.0–2.5% mol of the bis-triazole macrocycles were effective at accelerating the reactions
significantly, reaching 100% conversion at about 1–5 h. When using 2 mol% Cu(OAc)2
as the catalyst, the control reaction reached 13% conversion, but the reaction with DM35
reached 100% conversion at 2 h (Table S5).






Yield 301 h 2 h 5 h
1 None 0 0.01 2 5 27
2 None 0 0.05 33 51
3 DM35 2.5 0.01 29 52 74
4 DM35 1.0 0.02 58 88 100 86%
5 DM24 2.5 0.02 62 88 100 79%
6 DM25 1.0 0.05 77 98 86%
7 DM34 2.5 0.05 100 77%
8 DM35 2.5 0.05 100 87%
Conditions: Sugar azide (1.0 equiv, 40.0 mg), CuSO4·5H2O (0.05 equiv, 1.3 mg or other amount), 5-phenyl-1-
pentyne (1.5 equiv, 24.5 µL), EtOH/H2O (v/v 1:1, 2.0 mL), macrocycle (1.0–2.5 mol%), NaAsc (three folds of the
molar amount of copper sulfate).
For 4-t-butylphenylacetylene (Table 5 and Tables S7 and S8), using 0.1 equiv of copper
sulfate, the reactions were slow; only DM25 and DM35 helped the reaction to full conver-
sion at 20 h; when the CuSO4 loading was increased, the reactions in the presence of the
two MCs reached full conversions at 5 h. DM34 and DM24 were not that effective, giving
similar conversion compared to the control experiment. DM25 was much more efficient
than the isomer DM34—apparently, the positions of the triazoles in the macrocycle had an
influence towards the catalysis of the reaction.
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Table 5. Effect of the macrocycles on copper-mediated click reaction of sugar azide with 4-tert-






Yield 312 h 5 h 10 h 20 h
1 None 0 0.1 a 4 10 17
2 DM25 2.5 0.1 a 47 80 100 91%
3 DM34 2.5 0.1 a 15 34 70
4 DM35 2.5 0.1 a 28 45 100 86%
5 None 0 0.2 b 42 62 83
6 DM24 5.0 0.2 b 61 78 87
7 DM25 2.5 0.2 b 30 100 93%
8 DM25 5.0 0.2 b 43 100 95%
9 DM34 5.0 0.2 b 48 75 84
10 DM35 5.0 0.2 b 68 98 100 89%
Condition a: Sugar azide (1.0 equiv), CuSO4·5H2O (0.1 equiv), p-t-butyl-phenylacetylene (1.5 equiv), EtOH/H2O
(v/v 1:1, 2.0 mL), NaAsc (0.3 equiv); Condition b: The same as “a” except 0.2 equiv of CuSO4·H2O and 0.4 equiv
of NaAsc were used.
The energy minimized conformations of two macrocycles DM25 and DM34 are shown
in Figure 8 [35]. These two compounds have the same molecular weight and ring sizes—the
only difference is that the triazole is located at a different position to the anomeric center.
The two MCs adopted quite different conformations in which the triazoles rings are more
parallel in DM25, but at a dihedral angle about 30 degrees to each other for DM34. The two
triazole rings can adopt different conformations upon binding with copper, and possibly
have a cooperative effect when both triazole rings are embedded in the macrocycles. The
conformation difference of these MCs perhaps is correlating with the selectivity among
different alkynes. DM25 is more selective for phenylacetylene; it is also more effective
for t-Bu-phenylacetylene, while DM34 was the most effective MC for 1-octyne, but not
as good as other MCs for phenylacetylenes. The interesting selectivity towards different
alkynes may be useful in differentiating acetylenes when reacting with the azide; this could
be useful for other selective reactions.
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3. Experimental Section
General Methods
All reactions were carried out under normal conditions, reagents and solvents were
obtained commercially from Sigma-Aldrich, VWR, and Fisher and used directly with-
out purifications. All reactions, unless otherwise noted, were carried out in oven-dried
glassware under a nitrogen atmosphere. All purifications were conducted by flash chro-
matography using 230–400 mesh silica gel with a gradient of solvent systems. Thin-layer
chromatography (TLC) analysis was performed with aluminum-backed TLC plates with
UV and fluorescence indicator and visualized using UV lamp at 254 nm, then stained
with PMA solution. 1H NMR and proton-decoupled 13C NMR spectra were obtained
with Bruker 400 MHz NMR spectrometer in DMSO-d6, D2O, or CDCl3. The chemical
shifts were reported using CDCl3/DMSO-d6 as internal standard at 7.26/2.50 ppm and at
a) DM25 b) DM34 
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77.0/39.5 ppm, respectively. 2D NMR experiments (HSQC, COSY) were also conducted
to assist the compound characterizations. Melting point measurements were carried out
using a Fisher Jones melting point apparatus. The molecular mass was measured using
LC-MS on an Agilent LC1260 system and 6120B Single Quad Mass Spectrometer or with
Shimadzu LCMS-2020. HRMS data were obtained using positive electrospray ionization
on a Bruker 12T APEX-Qe FTICR-MS with an Apollo II ion source.
For compounds synthesized by similar methods, the procedures for the first com-
pound are included in detail. For the rest, only the amount used, purification method, and
the characterization data are provided.
Synthesis of compound 6a. Compound S3 (200.0 mg, 0.69 mmol, 1.0 equiv) was added
to a 50 mL round bottomed flask (RBF) with a drying tube and nitrogen balloon, pyridine
(4.0 mL) was added and the flask was cooled to 0 ◦C, then 4-bromobenzenesulfonyl chloride
(352.1 mg, 1.37 mmol, 2.0 equiv) was added and the mixture was stirred at 0 ◦C for 20 min
and the ice bath was removed. The mixture was stirred at rt for 20 h, at which time 1H
NMR spectrum showed about 95% conversion. The reaction was stopped, and solvent was
removed, the crude product was purified on silica gel using a gradient of dichloromethane
(DCM) and methanol, from DCM up to 10% MeOH/DCM (Rf = 0.31 in 10% MeOH/DCM).
The desired product 6a was obtained as a colorless liquid (232.0 mg, 66%). 1H NMR
(400 MHz, CDCl3) δ 7.78 (d, J = 8.6 Hz, 2H), 7.69 (d, J = 8.6 Hz, 2H), 6.21 (d, J = 8.8 Hz, 1H),
4.78 (d, J = 3.6 Hz, 1H), 4.38–4.29 (m, 2H), 4.11–4.04 (m, 1H), 3.87–3.78 (m, 2H), 3.71–3.65
(m, 1H), 3.60–3.54 (m, 1H), 3.53–3.46 (m, 2H), 3.37–3.29 (m, 1H), 2.02 (s, 3H); 13C NMR
(100 MHz, CDCl3) δ 172.3, 134.8, 132.6, 129.5, 129.2, 97.7, 73.4, 70.5, 69.9, 69.7, 67.2, 53.2,
50.5, 23.2. HRMS m/z calcd for C16H21BrN4O8SNa [M + Na]+ 531.0156, found 531.0155.
Synthesis of compound 6b. Compound S3 (100.0 mg, 0.35 mmol), pyridine (1.5 mL),
4-chlorobenzene sulfonyl chloride (147.7 mg, 0.69 mmol), 12 h. Purified by flash chro-
matography (DCM to 2% MeOH/DCM) to obtain a colorless liquid (122.0 mg, 76%) as
the desired compound. (Rf = 0.27 in 10% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ
7.86 (d, J = 8.6 Hz, 2H), 7.53 (d, J = 8.6 Hz, 2H), 6.12 (d, J = 8.7 Hz, 1H), 4.79 (d, J = 3.6 Hz,
1H), 4.39–4.25 (m, 2H), 4.11–4.03 (m, 1H), 3.90–3.83 (m, 1H), 3.83–3.77 (m, 1H), 3.71–3.64
(m, 1H), 3.61–3.45 (m, 3H), 3.38–3.29 (m, 1H), 2.02 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
172.2, 140.6, 134.3, 129.6, 129.4, 97.7, 72.8, 70.3, 69.9, 69.8, 67.2, 53.2, 50.4, 23.1. LC-MS (ESI+)
calcd for C16H22ClN4O8S [M+H]+ 465 found 465. HRMS (ESI+) ([M + Na]+) m/z calcd for
C16H21ClN4O8SNa, 487.0661, found 487.0665.
Synthesis of compound 6d. Compound S3 (200.0 mg, 0.69 mmol), pyridine (4.0 mL),
1-naphthalenesulfonyl chloride (312.4 mg, 1.37 mmol), 20 h to see 90% conversion. Purified
by flash chromatography (DCM to 10% MeOH/DCM) to obtain a white foam (211.0 mg,
64%) as the desired product. (Rf = 0.33 in 10% MeOH/DCM). 1H NMR (400 MHz, CDCl3)
δ 8.63 (d, J = 7.9 Hz, 1 H), 8.29 (dd, J = 8.4, 7.0 Hz, 1H), 8.13 (d, J = 8.2 Hz, 1H), 7.95 (d,
J = 8.0 Hz, 1H), 7.74–7.55 (m, 3H), 5.92 (d, J = 8.3 Hz, 1H), 4.61 (d, J = 3.7 Hz, 1H), 4.40–4.31
(m, 1H), 4.28–4.20 (m, 1H), 3.98–3.89 (m, 1H), 3.90–3.67 (m, 2H), 3.64–3.54 (m, 1H), 3.49–3.34
(m, 3H), 3.27–3.18 (m, 1H), 2.01 (s, 3H); 13C NMR (400 MHz, CDCl3) δ 172.1, 135.3, 134.1,
131.1, 130.4, 128.8, 128.5, 128.4, 127.2, 125.0, 124.0, 97.4, 72.7, 70.4, 69.9, 69.8, 66.9, 53.1, 50.3,
23.1. HRMS m/z calcd for C20H24N4O8SNa [M + Na]+ 503.1207, found 503.1208.
Synthesis of compound 7a. Compound 6a (100.0 mg, 0.2 mmol, 1.0 equiv) was added
to a 50 mL round bottom flask with a drying tube and nitrogen balloon attached, the
reaction flask was cooled to 0 ◦C, then dichloromethane (2.5 mL), pyridine (5.0 equiv) and
benzoyl chloride (0.06 mL, 0.5 mmol, 2.5 equiv) were added to the solution. The reaction
mixture was stirred at to 0 ◦C and then stirred at rt for about 12 h. At this time, TLC and
1H NMR indicated full conversion to the product. The reaction was stopped, and solvent
was removed under vacuum using a rotovap. The crude product was purified using flash
chromatography on silica gel using a solvent gradient of ethyl acetate and hexane from
1:4 to 3:2 ratio. The desired product was obtained as a colorless viscous liquid (112.0 mg,
79% yield). (Rf = 0.38 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.90–7.83 (m,
4H), 7.70 (d, J = 8.5 Hz, 2H), 7.58 (d, J = 8.5 Hz, 2H), 7.55–7.47 (m, 2H), 7.39–7.32 (m, 4H),
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5.90 (d, J = 9.1 Hz, 1H), 5.64 (t, J = 10.9 Hz, 1H), 5.38 (t, J = 9.9 Hz, 1H), 4.97 (d, J = 3.6 Hz,
1H), 4.56–4.49 (m, 1H), 4.28–4.16 (m, 3H), 4.00–3.94 (m, 1H), 3.72–3.65 (m, 1H), 3.62–3.55
(m, 1H), 3.45–3.38 (m, 1H), 1.85 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.1, 166.9, 165.1,
134.5, 133.7, 133.5, 132.5, 129.9, 129.8, 129.4, 129.3, 128.7, 128.5, 128.4, 97.6, 71.0, 68.8, 68.5,
68.4, 67.8, 52.0, 50.4, 23.0. HRMS m/z calcd for C30H29BrN4O10SNa [M + Na]+ 739.0680,
found 739.0676.
Synthesis of compound 7b. Compound 6b (100.0 mg, 0.22 mmol), DCM (3.0 mL) and
benzoyl chloride (0.06 mL, 0.54 mmol), 12 h. The crude was purified using flash chro-
matography on silica gel using a solvent gradient of DCM to 3% MeOH/DCM) to obtain
brown oil (96.0 mg, 86%) as the desired product. (Rf = 0.32 in 5% MeOH/DCM). 1H
NMR (400 MHz, CDCl3) δ 7.96–7.87 (m, 4H), 7.53–7.45 (m, 2H), 7.40–7.30 (m, 4H), 5.96 (d,
J = 9.3 Hz, 1H), 5.68 (t, J = 10.9 Hz, 1H), 5.47 (t, J = 9.9 Hz, 1H), 5.06 (d, J = 3.6 Hz, 1H),
4.65–4.55 (m, 1H), 4.26–4.18 (m, 1H), 4.12–4.03 (m, 1H), 3.78–3.71 (m, 1H), 3.71–3.63 (m,
2H), 3.63–3.56 (m, 1H), 3.48–3.39 (m, 1H), 1.86 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.1,
167.0, 165.2, 133.6, 133.5, 129.83, 129.81, 128.7, 128.6, 128.5, 128.4, 97.5, 71.2, 70.5, 70.3, 67.7,
52.1, 50.4, 43.6, 23.0. LC-HRMS m/z calcd for C24H25ClN4O7Na [M + Na]+ 539.1304, found
539.1301.
Synthesis of compound 8a. To a 50 mL RBF, 7a (100.0 mg, 0.14 mmol, 1.0 equiv) in
t-BuOH: THF: H2O (v:v:v 1:1:1, 3.0 mL) and 10-undecynoic acid (33.1 mg, 0.18 mmol,
1.3 equiv), CuSO4·5H2O (7.0 mg, 0.028 mmol, 0.2 equiv) and sodium ascorbate (NaAsc)
(11.1 mg, 0.056 mmol, 0.4 equiv) was added sequentially as described and stirred at rt
for 16 h. The reaction was monitored after 16 h by 1H NMR to see the consumption of
starting material and TLC to see no starting material at all. Further purified by flash
chromatography using DCM to 2% MeOH/DCM to obtain a white foam (112.0 mg, 89%) as
the desired product. (Rf = 0.26 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.88–7.79
(m, 4H), 7.68 (d, J = 8.6 Hz, 2H), 7.56 (d, J = 8.6 Hz, 2H), 7.53–7.44 (m, 3H), 7.38–7.30 (m, 4H),
6.15 (d, J = 9.0 Hz, 1H), 5.52 (t, J = 10.1 Hz, 1H), 5.32 (t, J = 9.8 Hz, 1H), 4.87 (d, J = 3.6 Hz,
1H), 4.60 (s, 2H), 4.53–4.44 (m, 1H), 4.20–4.06 (m, 3H), 4.02–3.94 (m, 1H), 3.92–3.84 (m, 1H),
2.70 (s, 2H), 2.30 (t, J = 7.3 Hz, 2H), 1.86 (s, 3H), 1.68–1.54 (m, 4H), 1.26 (m, 8H); 13C NMR
(100 MHz, CDCl3) δ 177.7, 170.6, 166.8, 165.0, 134.3, 133.6, 133.4, 132.5, 129.8, 129.7, 129.4,
129.2, 128.6, 128.5, 128.40, 128.37, 97.5, 71.1, 68.7, 68.4, 68.3, 66.6, 51.8, 49.6, 33.9, 29.2, 29.0,
28.91, 28.86, 25.5, 24.7, 22.9. HRMS m/z calcd for C41H47BrN4O12SNa [M + Na]+ 921.1990,
found 921.1994.
Synthesis of compound 8b. Compound 7b (90.0 mg, 0.17 mmol), t-BuOH: THF: H2O
(v:v:v 1:1:1, 2.5 mL), 10-undecynoic acid (31.7 mg, 0.17 mmol), CuSO4·5H2O (6.7 mg,
0.02 mmol), NaAsc (10.6 mg, 0.05 mmol), 5 h. The crude was purified by flash chromatog-
raphy (DCM to 3% MeOH/DCM) to obtain a colorless oil (68 mg, 56%) as the desired
product. (Rf = 0.24 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.94–7.86 (m, 4H),
7.54–7.46 (m, 2H), 7.44 (s, 1H), 7.40–7.32 (m, 4H), 6.13 (d, J = 9.2 Hz, 1H), 5.58 (dd, J = 10.7,
9.6 Hz, 1H), 5.41 (t, J = 9.6 Hz, 1H), 4.96 (d, J = 3.6 Hz, 1H), 4.70–4.59 (m, 2H), 4.59–4.51 (m,
1H), 4.31–4.20 (m, 1H), 4.03–3.89 (m, 2H), 3.68–3.57 (m, 2H), 2.73 (t, J = 7.6 Hz, 2H), 2.33 (t,
J = 7.3 Hz, 2H), 1.88 (s, 3H), 1.69–1.58 (m, 4H), 1.29 (m, 8H); 13C NMR (100 MHz, CDCl3) δ
170.6, 167.0, 165.2, 133.6, 133.5, 129.9, 129.8, 128.73, 128.65, 128.5, 128.4, 97.5, 71.4, 70.5, 70.3,
66.6, 52.0, 49.5, 43.6, 29.2, 28.9, 28.8, 28.7, 25.6, 23.0. HRMS m/z calcd for C35H43ClN4O9Na
[M + Na]+ 721.2611, found 721.2609.
Synthesis of compound 8c. Compound 7c (360.0 mg, 0.55 mmol), t-BuOH: THF: H2O
(v:v:v 1:1:1, 6.0 mL), 10-undecynoic acid (138.0 mg, 0.72 mmol), CuSO4·5H2O (18.0 mg,
0.108 mmol, 0.2 equiv), NaAsc (44.0 mg, 0.22 mmol), 12 h. Purified by flash chromatography
(DCM to 5% MeOH/DCM) to afford the colorless a semi-solid (378.0 mg, 82%) as the
desired product (Rf = 0.65 in 10% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.89–7.81
(m, 4H), 7.70 (d, J = 8.3 Hz, 2H), 7.55–7.43 (m, 3H), 7.40–7.30 (m, 4H), 7.21 (d, J = 8.1 Hz,
2H), 6.07 (d, J = 9.2 Hz, 1H), 5.54 (dd, J = 10.8, 9.6 Hz, 1H), 5.30 (t, J = 9.6 Hz, 1H), 4.86 (d,
J = 3.6 Hz, 1H), 4.65–4.56 (m, 2H), 4.51–4.43 (m, 1H), 4.22–4.04 (m, 4H), 3.93–3.85 (m, 1H),
2.72 (t, J = 7.7 Hz, 2H), 2.36 (s, 3H), 2.32 (t, J = 7.4 Hz, 2H), 1.86 (s, 3H), 1.71–1.57 (m, 4H),
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1.29 (m, 8H); 13C NMR (100 MHz, CDCl3) δ 177.0, 170.5, 166.9, 165.1, 148.8, 145.0, 133.6,
133.4, 132.3, 130.0, 129.9, 129.81, 129.78, 128.7, 128.6, 128.4, 128.0, 121.3, 97.5, 71.3, 68.9, 68.7,
68.2, 66.7, 51.9, 49.5, 33.8, 29.3, 29.0, 28.84, 28.82, 25.6, 24.7, 23.0, 21.6; HRMS m/z calcd for
C42H50N4O21SNa [M + Na]+ 857.3038, found 857.3039.
Synthesis of compound LM28 (13c). Compound 8c (100.0 mg, 0.12 mmol, 1.0 equiv),
K2CO3 (33.0 mg, 0.24 mmol, 2.0 equiv) and DMF (14 mL) were added to a 50 mL RBF. The
reaction mixture was stirred at 70 ◦C for 3 h, at which time 1H NMR spectrum and TLC
indicated the full conversion of starting materials. The reaction was stopped and solvent
was removed. The crude was purified via flash chromatography using an eluent of DCM
to 5% MeOH/DCM to obtain the desired product as a white solid (65.0 mg, 82%), Rf = 0.29
in 5% MeOH/DCM), m.p. 196.0 ◦C-198.0 ◦C; 1H NMR (400 MHz, CDCl3) δ ppm 7.95–7.86
(m, 4H), 7.54–7.45 (m, 2H), 7.42 (s, 1H), 7.40–7.31 (m, 4H), 6.00 (d, J = 9.2 Hz, 1H), 5.62
(dd, J = 10.9, 9.7 Hz, 1H), 5.45 (t, J = 9.7 Hz, 1H), 4.77–4.69 (m, 1H), 4.66 (d, J = 3.5 Hz,
1H), 4.62–4.54 (m, 1H), 4.51–4.43 (m, 1H), 4.41–4.34 (m, 1H), 4.13–4.01 (m, 4H), 2.87–2.78
(m, 1H), 2.77–2.67 (m, 1H), 2.31–2.20 (m, 1H), 2.19–2.09 (m, 1H), 1.93 (s, 3H), 1.79–1.60 (m,
2H), 1.56–1.43 (m, 2H), 1.29–1.09 (m, 8H); 13C NMR (100 MHz, CDCl3) δ 173.4, 170.2, 167.2,
165.4, 133.52, 133.47, 129.9, 129.8, 128.9, 128.8, 128.5, 128.4, 121.3, 97.7, 71.4, 70.2, 68.0, 65.0,
63.2, 52.6, 46.6, 33.7, 30.2, 28.20, 28.19, 28.1, 27.7, 27.2, 24.9, 24.4, 23.1; HRMS (ESI+) ([M +
Na]+) m/z calcd for C35H42N4O9Na, 685.2844, found 685.2825.
Synthesis of compounds LM28 and DLM28. Compound 8a (100.0 mg, 0.11 mmol,
1.0 equiv), DMF (7.0 mL), and K2CO3 (30.7 mg, 0.22 mmol, 2.0 equiv) were added to
a 50 mL RBF. The reaction mixture was stirred at 75 ◦C for 5 h, the 1H NMR and TLC
samples showed complete conversion of the starting materials. The crude was purified
by flash chromatography using DCM to 5% MeOH DCM to obtain the desired compound
LM28 (53.0 mg, 0.080 mmol, 72%) along with some later fraction which was identified as
the dimerization product DLM28 as a white solid (15.0 mg, 0.011 mmol, 20% based on
starting material conversion). The chloro compound 8b was cyclized by similar conditions,
using compound 8b (50.0 mg, 0.07 mmol, 1.0 equiv), DMF (7.0 mL), and K2CO3 (19.8 mg,
0.14 mmol, 2.0 equiv). The desired compound LM28 (31.7 mg, 0.048 mmol, 67%) and
DLM28 (8.0 mg, 0.006 mmol, 17% based on starting material conversion) were obtained.
Characterization for DLM28: Rf = 0.18 in 5% MeOH/DCM. m.p. 236.0–238.0 ◦C; 1H
NMR (400 MHz, CDCl3) δ 7.92–7.87 (m, 8H), 7.51–7.46 (m, 6H), 7.37–7.31 (m, 8H), 6.06 (d,
J = 9.1 Hz, 2H), 5.58 (dd, J = 10.3, 9.5 Hz, 2H), 5.43 (t, J = 9.8 Hz, 2H), 4.89 (d, J = 3.5 Hz, 2H),
4.63–4.50 (m, 6H), 4.21–4.11 (m, 6H), 3.95–3.88 (m, 4H), 2.72 (t, J = 7.6 Hz, 4H), 2.27–2.22
(m, 4H), 1.89 (s, 6H), 1.70–1.66 (m, 4H), 1.59–1.54 (m, 4H), 1.33–1.23 (m, 16H); 13C NMR
(100 MHz, CDCl3) δ 173.2, 170.3, 166.9, 165.2, 133.5, 133.4, 129.83, 129.77, 128.87, 128.85,
128.4, 121.3, 97.7, 71.4, 69.3, 68.6, 66.8, 62.6, 52.0, 49.5, 34.0, 29.2, 28.93, 28.88, 28.8, 25.6, 24.7,
23.1. HRMS m/z calcd for C70H84N8O18Na [M + Na]+ 1347.5796, found 1347.5797.
Synthesis of compound 10d. 3-azido propionic acid (200.0 mg, 1.74 mmol, 1.0 equiv)
and 1,7-octadiyne (276.0 mg, 2.6 mmol, 1.5 equiv) were dissolved in t-BuOH: THF: H2O
(v:v:v 1:1:1, 25.0 mL), then CuSO4·5H2O (84.8 mg, 0.34 mmol, 0.2 equiv), NaAsc (134.7 mg,
0.68 mmol, 0.4 equiv) were added to the reaction mixture. The reaction was stirred at rt
for 24 h, at which time the reaction was completed as indicated by 1H NMR and TLC. The
reaction was stopped, and solvent was removed using a rotovap, the residue was diluted
with EtOAc and acidified using 0.1 N HCl (5.0 mL) followed by water wash. The organic
layer was collected and dried over anhydrous Na2SO4 and solvent was removed under
vacuum to obtain the crude, which was further purified with flash chromatography using
eluent of hexanes to 60% EtOAc/Hexanes to obtain the desired product as a yellowish solid
(272.0 mg, 71%), Rf = 0.48 in 80% EtOAc/Hexanes, m.p. 93.5–94.5 ◦C; 1H NMR (400 MHz,
CDCl3) δ 8.98 (br s, 1H), 7.47 (s, 1H), 4.66 (t, J = 6.5 Hz, 2H), 3.02 (t, J = 6.5 Hz, 2H), 2.75 (t,
J = 7.6 Hz, 2H), 2.23–2.18 (m, 2H), 1.92 (t, J = 2.6 Hz, 1H), 1.82–1.73 (m, 2H), 1.62–1.54 (m,
2H); 13C NMR (100 MHz, CDCl3) δ 173.2, 147.7, 121.8, 84.2, 68.5, 45.7, 34.7, 28.3, 27.9, 24.9,
18.1. HRMS m/z calcd for C11H15N3O2Na [M + Na]+ 244.1056, found 244.1056.
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Synthesis of compound 10e. The same procedure for compound 10d was used, 3-
azido propionic acid (200.0 mg, 1.74 mmol), t-BuOH: THF: H2O (v:v:v 1:1:1, 25.0 mL),
1,8-nonadiyne (313.3 mg, 2.6 mmol), CuSO4·5H2O (84.8 mg, 0.34 mmol), NaAsc (134.7 mg,
0.68 mmol), 24 h. The product was purified using flash chromatography (Hexanes to
30% EtOAc/Hexanes) to obtain a yellowish solid (306.0 mg, 75%) as the desired product
(Rf = 0.5 in 80% EtOAc/Hexanes). m.p. 137.5–139.0 ◦C; 1H NMR (400 MHz, CDCl3) 7.39
(s, 1H), 4.62 (t, J = 6.5 Hz, 2H), 3.02 (t, J = 6.5 Hz, 2H), 2.71 (t, J = 7.7 Hz, 2H), 2.23–2.13 (m,
2H), 1.93 (t, J = 2.7 Hz, 1H), 1.72–1.64 (m, 2H), 1.59–1.51 (m, 2H), 1.50–1.43 (m, 2H); 13C
NMR (100 MHz, CDCl3) δ 173.0, 148.0, 121.6, 84.5, 68.3, 45.5, 34.6, 28.8, 28.3, 28.2, 25.4, 18.3.
HRMS (ESI+) m/z calcd for C12H17N3O2Na [M + Na]+ 258.1213, found 258.1212.
Synthesis of compound 11a. Compound 7c (100.0 mg, 0.15 mmol), t-BuOH: THF:
H2O (v:v:v 1:1:1, 3.0 mL), 6-heptynoic acid (25.2 mg, 0.2 mmol), CuSO4·5H2O (7.7 mg,
0.03 mmol), NaAsc (12.1 mg, 0.06 mmol), 16 h. Purified by flash chromatography (DCM
to 3% MeOH/DCM) to obtain a colorless slurry (96.0 mg, 81%) as the desired product
(Rf = 0.32 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.88–7.83 (m, 4H), 7.70 (d,
J = 8.2 Hz, 2H), 7.67 (s, 1H), 7.55–7.47 (m, 3H), 7.40–7.32 (m, 5H), 7.22 (d, J = 8.0 Hz, 2H),
6.45 (d, J = 8.8 Hz, 1H), 5.62 (t, J = 10.1 Hz, 1H), 5.31 (t, J = 9.4 Hz, 1H), 4.90 (d, J = 3.6 Hz,
1H), 4.70–4.59 (m, 2H), 4.57–4.49 (m, 1H), 4.22–4.07 (m, 4H), 3.97–3.90 (m, 1H), 2.85–2.77 (m,
2H), 2.43–2.34 (m, 5H), 1.85 (s, 3H), 1.81–1.68 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 176.5,
170.6, 167.5, 165.1, 145.1, 133.8, 133.6, 132.3, 129.9, 129.8, 128.53, 128.46, 128.0, 97.2, 71.6, 69.1,
68.5, 68.3, 66.4, 51.8, 32.8, 27.8, 24.9, 23.5, 22.9, 21.6. HRMS m/z calcd for C38H42N4O12SNa
[M + Na]+ 801.2412, found 801.2406.
Synthesis of compound 11b. Compound 7c (100.0 mg, 0.15 mmol), t-BuOH: THF: H2O
(v:v:v 1:1:1, 3.0 mL), 8-nonynoic acid (30.7 mg, 0.2 mmol), CuSO4·5H2O (7.7 mg, 0.03
mmol), NaAsc (12.1 mg, 0.06 mmol), 16 h. Purified by flash chromatography (DCM to 3%
MeOH/DCM) to obtain a colorless slurry (109.0 mg, 88%) as the desired product (Rf = 0.38
in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.88–7.82 (m, 4H), 7.70 (d, J = 8.0 Hz,
2H), 7.54–7.45 (m, 3H), 7.38–7.30 (m, 4H), 7.21 (d, J = 7.9 Hz, 2H), 6.15 (d, J = 6.9 Hz, 1H),
5.55 (t, J = 10.1 Hz, 1H), 5.29 (t, J = 8.6 Hz, 1H), 4.86 (d, J = 2.4 Hz, 1H), 4.60 (br s, 2H),
4.52–4.43 (m, 1H), 4.20–4.05 (m, 4H), 3.90–3.84 (m, 1H), 2.73 (br s, 2H), 2.35 (s, 3H), 2.31
(t, J = 7.2 Hz, 2H), 1.86 (s, 3H), 1.72–1.58 (m, 4H), 1.38–1.33 (m, 4H); 13C NMR (100 MHz,
CDCl3) δ 176.6, 169.6, 165.9, 164.1, 144.1, 132.6, 132.5, 131.3, 128.9, 128.8, 127.7, 127.6, 127.4,
127.0, 96.5, 70.3, 67.9, 67.6, 67.3, 65.5, 50.8, 32.7, 27.47, 27.45, 23.5, 20.6. HRMS m/z calcd for
C40H46N4O12SNa [M + Na]+ 829.2725, found 829.2722.
Synthesis of compound 12a. Compound 9 (100.0 mg, 0.15 mmol), t-BuOH: THF:
H2O (v:v:v 1:1:1, 2.5 mL), 6-heptynoic acid (24.6 mg, 0.19 mmol), CuSO4·5H2O (7.5 mg,
0.03 mmol), NaAsc (11.8 mg, 0.06 mmol), 24 h. Purified by flash chromatography (DCM
to 2% MeOH/DCM) to obtain a colorless slurry (98.0 mg, 82%) as the desired product
(Rf = 0.22 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.92–7.83 (m, 4H), 7.69
(d, J = 8.3 Hz, 2H), 7.56–7.46 (m, 3H), 7.40–7.32 (m, 4H), 7.21 (d, J = 8.2 Hz, 2H), 6.43 (d,
J = 9.2 Hz, 1H), 5.61 (t, J = 10.1 Hz, 1H), 5.32 (t, J = 10.0 Hz, 1H), 4.88 (d, J = 3.6 Hz, 1H),
4.66–4.57 (m, 1H), 4.54–4.42 (m, 2H), 4.31–4.23 (m, 1H), 4.21–4.08 (m, 2H), 3.82–3.74 (m,
1H), 3.43–3.33 (m, 1H), 2.79 (t, J = 6.7 Hz, 2H), 2.42–2.33 (m, 5H), 2.29–2.19 (m, 2H), 1.93 (s,
3H), 1.81–1.64 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 176.4, 170.9, 167.1, 165.2, 148.1, 145.0,
133.6, 132.3, 129.9, 129.8, 128.7, 128.6, 128.5, 128.4, 128.0, 121.3, 97.1, 71.5, 69.1, 68.5, 68.4,
64.5, 52.1, 46.8, 33.1, 29.6, 28.2, 25.0, 23.8, 23.0, 21.6. HRMS m/z calcd for C39H44N4O12SNa
[M + Na]+ 815.2569, found 815.2564.
Synthesis of compound 12b. Compound 9 (100.0 mg, 0.15 mmol), t-BuOH: THF: H2O
(v:v:v 1:1:1, 2.5 mL), 8-nonynoic acid (30.1 mg, 0.19 mmol), CuSO4·5H2O (7.5 mg, 0.03 mmol),
NaAsc (11.8 mg, 0.06 mmol), 24 h. Purified by flash chromatography (DCM to 2%
MeOH/DCM) to obtain a colorless slurry (106.0 mg, 86%) as the desired product (Rf = 0.23
in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.92–7.84 (m, 4H), 7.69 (d, J = 8.2 Hz,
2H), 7.56–7.46 (m, 2H), 7.41–7.31 (m, 5H), 7.21 (d, J = 8.2 Hz, 2H), 6.38 (d, J = 9.2 Hz, 1H),
5.60 (t, J = 10.0 Hz, 1H), 5.31 (t, J = 9.9 Hz, 1H), 4.84 (d, J = 3.5 Hz, 1H), 4.67–4.57 (m, 1H),
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4.55–4.43 (m, 2H), 4.31–4.24 (m, 1H), 4.20–4.07 (m, 2H), 3.87–3.78 (m, 1H), 3.40–3.31 (m, 1H),
2.74 (t, J = 7.5 Hz, 2H), 2.38–2.18 (m, 7H), 1.95 (s, 3H), 1.74–1.59 (m, 4H), 1.42–1.32 (m, 4H);
13C NMR (100 MHz, CDCl3) δ 176.9, 170.8, 167.0, 165.2, 148.5, 145.0, 133.54, 133.48, 132.3,
129.9, 129.8, 128.8, 128.7, 128.4, 128.0, 120.9, 97.5, 71.5, 69.2, 68.6, 68.5, 64.8, 52.0, 46.9, 33.5,
29.9, 28.9, 28.44, 28.37, 25.2, 24.5, 23.0, 21.6. HRMS m/z calcd for C41H48N4O12SNa [M +
Na]+ 843.2882, found 843.2876.
Synthesis of compound 12c. Compound 9 (100.0 mg, 0.15 mmol), t-BuOH: THF: H2O
(v:v:v 1:1:1, 2.5 mL), 10-undecynoic acid (35.5 mg, 0.19 mmol), CuSO4·5H2O (7.5 mg,
0.03 mmol), NaAsc (11.8 mg, 0.06 mmol), 24 h. Purified by flash chromatography using
(DCM to 2% MeOH/DCM) to obtain a colorless slurry (98.0 mg, 77%) as the desired
product (Rf = 0.27 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.91–7.84 (m, 4H),
7.69 (d, J = 8.2 Hz, 2H), 7.55–7.44 (m, 2H), 7.41–7.30 (m, 5H), 7.20 (d, J = 8.2 Hz, 2H), 6.44
(d, J = 9.2 Hz, 1H), 5.59 (t, J = 10.1 Hz, 1H), 5.31 (t, J = 9.8 Hz, 1H), 4.83 (d, J = 3.5 Hz, 1H),
4.70–4.57 (m, 1H), 4.56–4.43 (m, 2H), 4.32–4.23 (m, 1H), 4.20–4.06 (m, 2H), 3.89–3.80 (m,
1H), 3.40–3.28 (m, 1H), 2.72 (t, J = 7.6 Hz, 2H), 2.37–2.17 (m, 7H), 1.94 (s, 3H), 1.71–1.55
(m, 4H), 1.39–1.24 (m, 8H); 13C NMR (100 MHz, CDCl3) δ 177.8, 170.8, 166.9, 165.2, 148.9,
145.0, 133.5, 133.4, 132.3, 129.84, 129.79, 129.77, 128.8, 128.6, 128.4, 128.1, 128.0, 120.7, 97.5,
71.4, 69.2, 68.5, 68.4, 64.8, 51.9, 46.8, 33.9, 29.9, 29.2, 28.92, 28.89, 28.85, 25.5, 24.6, 23.0, 21.6;
HRMS m/z calcd for C43H52N4O12SNa [M + Na]+ 871.3195, found 871.3192.
Synthesis of compound 13a (LM24). Compound 11a (74.0 mg, 0.095 mmol, 1.0 equiv),
DMF (13.0 mL), K2CO3 (26.3 mg, 0.19 mmol, 2.0 equiv, 75 ◦C for 2 h. Purified by flash
chromatography using (DCM to 3% MeOH/DCM) to obtain a white solid (51.0 mg, 88%)
as the desired product (Rf = 0.32 in 5% MeOH/DCM). m.p. 123.0–125.0 ◦C; 1H NMR (400
MHz, CDCl3) δ 7.98–7.86 (m, 4H), 7.54–7.46 (m, 3H), 7.41–7.32 (m, 4H), 6.18 (d, J = 8.6 Hz,
1H), 5.62 (dd, J = 10.9, 9.6 Hz, 1H), 5.36 (t, J = 9.9 Hz, 1H), 5.02 (d, J = 3.6 Hz, 1H), 4.87–4.77
(m, 1H), 4.64–4.55 (m, 1H), 4.50–4.42 (m, 1H), 4.22 (dd, J = 11.9, 4.4 Hz, 1H), 4.13–3.94 (m,
3H), 3.63–3.55 (m, 1H), 2.96–2.86 (m, 1H), 2.72–2.61 (m, 1H), 2.30–2.21 (m, 1H), 2.01–1.93
(m, 1H), 1.91 (s, 3H), 1.63–1.48 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 172.3, 170.2, 167.2,
165.5, 148.6, 133.6, 133.5, 129.91, 128.87, 128.8, 128.7, 128.5, 128.4, 120.6, 97.2, 71.0, 70.4, 69.1,
68.6, 64.5, 52.8, 50.0, 33.7, 28.2, 24.7, 23.2, 23.1; HRMS m/z calcd for C31H34N4O9Na [M +
Na]+ 629.2218, found 629.2222.
Synthesis of compound 13b (LM26). Compound 11b (100.0 mg, 0.12 mmol), DMF
(10.0 mL), K2CO3 (34.3 mg, 0.24 mmol), 75 ◦C for 5 h. Purified by flash chromatography
(DCM to 5% MeOH/DCM) to obtain a white solid (60.0 mg, 76%) as the desired product
(Rf = 0.29 in 5% MeOH/DCM). m.p. 108.0–110.0 ◦C; 1H NMR (400 MHz, CDCl3) δ 7.97–
7.87 (m, 4H), 7.54–7.45 (m, 3H), 7.41–7.31 (m, 4H), 6.21 (d, J = 9.1 Hz, 1H, -NH), 5.62
(dd, J = 10.9, 9.5 Hz, 1H, H-3), 5.37 (t, J = 9.8 Hz, 1H, H-4), 4.99 (d, J = 3.6 Hz, 1H, H–1),
4.72–4.67 (m, 2H, -O-CH2-CH2-N), 4.59–4.50 (m, 1H, H-2), 4.22–4.02 (m, 3H, H-6a, H-6b,
-O-CHa-CH2-N), 4.00–3.93 (m, 1H, -O-CHb-CH2-N), 3.87–3.78 (m, 1H, H-5), 2.90–2.71 (m,
2H, -HC=C-CH2-CH2-), 2.16–1.98 (m, 2H, -OOC-CH2-CH2-), 1.90 (s, 3H), 1.80–1.68 (m, 1H),
1.67–1.55 (m, 1H), 1.54–1.40 (m, 2H), 1.28–1.07 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 173.3,
170.1, 167.0, 165.3, 148.5 (HC=C-), 133.5, 129.83, 128.79, 128.7, 128.44, 128.42, 120.8 (HC=C-),
97.3 (C-1), 71.1 (C-3), 70.4 (C-4), 68.5 (C-5), 67.1 (-O-CH2-CH2-N), 64.1 (C-6), 52.3 (C-2), 49.6
(-O-CH2-CH2-N), 32.9, 27.9, 27.4, 25.9, 24.7, 23.7, 23.1; HRMS m/z calcd for C33H38N4O9Na
[M + Na]+ 657.2531, found 657.2529.
Synthesis of compound 14a (LM34). Compound 12a (96.0 mg, 0.12 mmol), DMF
(10.0 mL), K2CO3 (33.5 mg, 0.24 mmol), 75 ◦C for 2 h. Purified by flash chromatogra-
phy (DCM to 3% MeOH/DCM) to obtain a colorless liquid which turns into a white solid
over time (66.3 mg, 88%) as the desired product (Rf = 0.2 in 5% MeOH/DCM). m.p. 117.0–
118.0 ◦C; 1H NMR (400 MHz, CDCl3) δ 7.97–7.85 (m, 4H), 7.54–7.45 (m, 2H), 7.42–7.31
(m, 5H), 5.88 (d, J = 9.2 Hz, 1H), 5.65 (t, J = 10.2 Hz, 1H), 5.31 (t, J = 9.6 Hz, 1H), 4.93 (d,
J = 3.6 Hz, 1H), 4.75–4.66 (m, 1H), 4.57–4.42 (m, 2H), 4.19–4.01 (m, 3H), 3.55–3.37 (m, 2H),
2.90–2.70 (m, 2H), 2.43–2.16 (m, 4H), 1.87 (s, 3H), 1.79–1.72 (m, 2H), 1.69–1.62 (m, 2H),
1.53–1.45 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 172.4, 169.9, 167.2, 165.3, 147.3, 133.5,
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129.9, 129.8, 128.7, 128.5, 126.9, 121.2, 97.4, 71.4, 69.5, 68.6, 64.8, 64.0, 52.3, 46.6, 41.0, 34.3,
29.8, 27.3, 24.4, 23.3, 23.2; HRMS m/z calcd for C32H36N4O9Na [M + Na]+ 643.2375, found
643.2374.
Synthesis of compound 14b (LM36). Compound 12b (86.0 mg, 0.10 mmol), DMF
(10.0 mL), K2CO3 (28.9 mg, 0.20 mmol), 75 ◦C for 2 h. Purified by flash chromatogra-
phy (DCM to 3% MeOH/DCM) to obtain a white solid (56.6 mg, 83%) as the desired
product (Rf = 0.3 in 5% MeOH/DCM). m.p. 97.0–98.0 ◦C; 1H NMR (400 MHz, CDCl3) δ
7.98–7.86 (m, 4H), 7.53–7.46 (m, 2H), 7.40–7.31 (m, 5H), 5.95 (d, J = 9.1 Hz, 1H), 5.67 (t,
J = 10.2 Hz, 1H), 5.35 (t, J = 9.7 Hz, 1H), 4.98 (d, J = 3.6 Hz, 1H), 4.69–4.60 (m, 1H), 4.55–4.48
(m, 1H), 4.47–4.39 (m, 1H), 4.24–4.09 (m, 3H), 3.66–3.51 (m, 2H), 2.86–2.68 (m, 2H), 2.43–2.24
(m, 2H), 2.08 (t, J = 7.0 Hz, 2H), 1.88 (s, 3H), 1.74–1.64 (m, 2H), 1.61–1.47 (m, 2H), 1.33–1.16
(m, 4H); 13C NMR (100 MHz, CDCl3) δ 173.2, 169.9, 167.2, 165.4, 148.1, 133.53, 133.51,
130.0, 129.84, 128.79, 128.7, 128.46, 128.45, 120.9, 98.0, 71.4, 70.0, 68.5, 65.5, 63.8, 52.6, 46.6,
32.4, 30.3, 27.4, 26.6, 25.7, 24.6, 23.5, 23.2; HRMS m/z calcd for C34H40N4O9Na [M + Na]+
671.2688, found 671.2686.
Synthesis of compound 14c (LM38). Compound 12c (90.0 mg, 0.11 mmol), DMF (10.0 mL),
K2CO3 (30.4 mg, 0.20 mmol), 75 ◦C for 2 h. Purified by flash chromatography (DCM to
2% MeOH/DCM) to obtain a white solid (59.5 mg, 83%) as the desired product (Rf = 0.32
in 5% MeOH/DCM). m.p. 87.0–89.0 ◦C; 1H NMR (400 MHz, CDCl3) δ 7.97–7.88 (m, 4H),
7.54–7.47 (m, 2H), 7.41–7.31 (m, 5H), 6.12 (d, J = 8.8 Hz, 1H), 5.62 (t, J = 10.6 Hz, 1H), 5.44
(t, J = 9.8 Hz, 1H), 4.91 (d, J = 3.6 Hz, 1H), 4.61–4.42 (m, 3H), 4.33–4.12 (m, 3H), 3.71–3.61
(m, 1H), 3.46–3.36 (m, 1H), 2.88–2.71 (m, 2H), 2.33–2.04 (m, 4H), 1.93 (s, 3H), 1.75–1.68 (m,
4H), 1.56–1.47 (m, 2H), 1.28–1.15 (m, 8H); 13C NMR (100 MHz, CDCl3) δ 173.4, 170.2, 167.2,
165.4, 133.52, 133.47, 129.9, 129.8, 128.9, 128.8, 128.5, 128.4, 121.3, 97.7, 71.4, 70.2, 68.0, 65.0,
63.2, 52.6, 46.6, 33.7, 30.2, 28.20, 28.19, 28.14, 27.7, 27.2, 24.9, 24.4, 23.1; HRMS m/z calcd for
C36H44N4O9Na [M + Na]+ 699.3001, found 699.3000.
Compounds 15a-b and 16a-b were prepared similarly as compound 8a.
Synthesis of compound 15a. Compound 7c (200.0 mg, 0.31 mmol, 1.0 equiv), t-BuOH:
THF: H2O (v:v:v 1:1:1, 3.0 mL), 10d (89.2 mg, 0.4 mmol, 1.3 equiv), CuSO4·5H2O (15.5 mg,
0.062 mmol, 0.2 equiv), NaAsc (24.6 mg, 0.124 mmol, 0.4 equiv), 24 h. Purified by flash
chromatography (DCM to 3% MeOH/DCM) to obtain a yellowish slurry (209.0 mg, 78%) as
the desired product (Rf = 0.5 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.86–7.80
(m, 4H), 7.68 (d, J = 8.3 Hz, 2H), 7.54–7.46 (m, 2H), 7.45 (s, 1H), 7.41 (s, 1H), 7.38–7.29
(m, 4H), 7.20 (d, J = 8.0 Hz, 2H), 6.26 (d, J = 9.1 Hz, 1H), 5.54 (t, J = 10.8 Hz, 1H), 5.28 (t,
J = 9.6 Hz, 1H), 4.84 (d, J = 3.6 Hz, 1H), 4.63–4.55 (m, 4H), 4.49–4.42 (m, 1H), 4.20–4.04
(m, 4H), 3.89–3.83 (m, 1H), 2.91 (t, J = 6.2 Hz, 2H), 2.76–2.66 (m, 4H), 2.34 (s, 3H), 1.82 (s,
3H), 1.75–1.62 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 172.6, 171.0, 166.7, 165.1, 148.2, 147.3,
145.1, 133.6, 133.4, 132.3, 129.9, 129.81, 129.75, 128.7, 128.6, 128.4, 128.0, 122.2, 121.6, 97.5,
71.2, 68.9, 68.6, 68.2, 66.7, 51.9, 49.6, 45.9, 35.1, 28.5, 28.3, 25.2, 25.0, 22.8, 21.6. HRMS m/z
calcd for C42H47N7O12SNa [M + Na]+ 896.2896, found 896.2886.
Synthesis of compound 15b. Compound 7c (100.0 mg, 0.15 mmol, 1.0 equiv), t-BuOH:
THF: H2O (v:v:v 1:1:1, 3.0 mL), 10e (46.8 mg, 0.19 mmol, 1.3 equiv), CuSO4·5H2O (7.3 mg,
0.03 mmol, 0.2 equiv), NaAsc (12.3 mg, 0.06 mmol, 0.4 equiv), 24 h. Purified by flash
chromatography (DCM to 2% MeOH/DCM) to obtain a yellowish slurry (108.0 mg, 79%)
as the desired product (Rf = 0.41 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ
7.88–7.81 (m, 4H), 7.69 (d, J = 8.3 Hz, 2H), 7.54–7.47 (m, 2H), 7.45 (s, 1H), 7.40 (s, 1H),
7.38–7.30 (m, 4H), 7.21 (d, J = 7.9 Hz, 2H), 6.11 (d, J = 9.1 Hz, 1H), 5.53 (t, J = 10.8 Hz,
1H), 5.28 (t, J = 9.6 Hz, 1H), 4.86 (d, J = 3.6 Hz, 1H), 4.64–4.58 (m, 4H), 4.50–4.42 (m, 1H),
4.21–4.07 (m, 4H), 3.93–3.86 (m, 1H), 2.91 (t, J = 6.2 Hz, 2H), 2.73–2.65 (m, 4H), 2.35 (s, 3H),
1.83 (s, 3H), 1.70–1.59 (m, 4H), 1.36–1.28 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 172.5, 170.8,
166.8, 165.1, 148.4, 147.5, 145.1, 133.6, 133.5, 132.3, 129.83, 129.77, 128.7, 128.6, 128.4, 128.0,
122.2, 121.6, 97.5, 71.2, 68.9, 68.7, 68.2, 66.6, 51.9, 49.6, 45.8, 35.1, 29.0, 28.4, 28.0, 25.3, 25.0,
22.9, 21.6. HRMS m/z calcd for C43H49N7O12SNa [M + Na]+ 910.3052, found 910.3043.
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Synthesis of compound 15c. To a 50 mL RBF, compound 9 (100.0 mg, 0.15 mmol,
1.0 equiv), t-BuOH: THF: H2O (v:v:v 1:1:1, 3.0 mL), 10d (43.1 mg, 0.19 mmol, 1.3 equiv),
CuSO4·5H2O (7.3 mg, 0.03 mmol, 0.2 equiv), NaAsc (12.3 mg, 0.06 mmol, 0.4 equiv), 16 h.
Purified by flash chromatography (DCM to 5% MeOH/DCM) to obtain a yellowish slurry
(116.0 mg, 87%) as the desired product (Rf = 0.41 in 5% MeOH/DCM). 1H NMR (400 MHz,
CDCl3) δ 7.91–7.85 (m, 4H), 7.68 (d, J = 8.3 Hz, 2H), 7.56–7.46 (m, 2H), 7.43 (s, 1H), 7.40–7.31
(m, 5H), 7.20 (d, J = 8.1 Hz, 2H), 6.39 (d, J = 9.1 Hz, 1H), 5.59 (t, J = 9.7 Hz, 1H), 5.31 (t,
J = 9.7 Hz, 1H), 4.84 (d, J = 3.5 Hz, 1H), 4.68–4.56 (m, 3H), 4.54–4.42 (m, 2H), 4.33–4.24
(m, 1H), 4.20–4.07 (m, 2H), 3.86–3.78 (m, 1H), 3.34–3.26 (m, 1H), 2.88 (t, J = 5.9 Hz, 2H),
2.78–2.66 (m, 4H), 2.35 (s, 3H), 2.32–2.16 (m, 2H), 1.94 (s, 3H), 1.80–1.59 (m, 4H); 13C NMR
(100 MHz, CDCl3) δ 171.2, 166.9, 165.2, 148.3, 147.3, 145.0, 133.5, 133.4, 132.3, 129.9, 129.8,
128.8, 128.7, 128.4, 128.0, 122.4, 120.9, 97.5, 71.4, 69.1, 68.6, 68.4, 64.8, 52.1, 46.8, 46.0, 35.4,
29.7, 28.5, 28.3, 25.04, 24.96, 23.0, 21.6. HRMS m/z calcd for C43H49N7O12SNa [M + Na]+
910.3052, found 910.3043.
Synthesis of compound 15d. Compound 9 (100.0 mg, 0.15 mmol, 1.0 equiv), t-BuOH:
THF: H2O 1:1:1 (v:v:v 1:1:1, 3.0 mL), 10e (45.9 mg, 0.19 mmol, 1.3 equiv), CuSO4·5H2O
(7.3 mg, 0.03 mmol, 0.2 equiv), NaAsc (11.9 mg, 0.06 mmol, 0.4 equiv), 16 h. Purified by
flash chromatography (DCM to 5% MeOH/DCM) to obtain a yellowish slurry (113.0 mg,
83%) as the desired product (Rf = 0.46 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3)
δ 7.90–7.84 (m, 4H), 7.69 (d, J = 8.3 Hz, 2H), 7.56–7.45 (m, 2H), 7.44–7.30 (m, 6H), 7.21 (d,
J = 8.2 Hz, 2H), 6.36 (d, J = 9.1 Hz, 1H), 5.59 (t, J = 9.7 Hz, 1H), 5.31 (t, J = 9.7 Hz, 1H),
4.84 (d, J = 3.5 Hz, 1H), 4.66–4.57 (m, 3H), 4.54–4.46 (m, 2H), 4.31–4.25 (m, 1H), 4.20–4.08
(m, 2H), 3.87–3.80 (m, 1H), 3.38–3.20 (m, 1H), 2.90 (t, J = 6.0 Hz, 2H), 2.73–2.65 (m, 4H),
2.35 (s, 3H), 2.32–2.19 (m, 2H), 1.93 (s, 3H), 1.73–1.59 (m, 4H), 1.36–1.25 (m, 2H); 13C NMR
(100 MHz, CDCl3) δ 170.8, 167.0, 165.2, 148.6, 147.5, 145.0, 133.54, 133.46, 132.3, 129.9, 129.8,
128.8, 128.7, 128.4, 128.0, 122.2, 121.0, 97.5, 71.5, 69.1, 68.6, 68.4, 64.8, 52.0, 47.0, 45.9, 35.2,
29.9, 29.0, 28.4, 28.0, 25.2, 25.0, 23.0, 21.6. HRMS m/z calcd for C44H51N7O12SNa [M + Na]+
924.3209, found 924.3213.
Compounds 16a-d, 22, 24 were prepared similarly as for compound 13c. The amount
of all chemicals, reaction time, yield, Rf value, and characterization of the product are listed,
respectively. The macrocycles were typically obtained first as a clear waxy liquid, which
upon standing for a few days, turned to a white solid.
Synthesis of compound 16a (DM24). Compound 15a (75.0 mg, 0.086 mmol), DMF
(12.0 mL), K2CO3 (23.7 mg, 0.17 mmol), 85 ◦C for 4.0 h. The crude was purified by flash
chromatography (DCM to 2% MeOH/DCM) to obtain a white solid (54.0 mg, 90%) as the
desired product 16a (Rf = 0.14 in 5% MeOH/DCM). The reaction was also carried out using
CH3CN as the solvent: Compound 15a (50.0 mg, 0.057 mmol) was dissolved in CH3CN
(12.0 mL), then K2CO3 (15.8 mg, 0.11 mmol) was added, the reaction mixture was stirred at
75 ◦C for 11.0 h. The solvent was removed using a rotavap, and the crude was purified
using flash column similarly to give the pure product (31.0 mg, 77%). m.p. 127.0–129.0 ◦C;
1H NMR (400 MHz, CDCl3) δ 7.94–7.86 (m, 4H), 7.54–7.44 (m, 2H), 7.39–7.32 (m, 5H), 7.30
(s, 1H), 5.96 (d, J = 9.3 Hz, 1H), 5.55 (t, J = 10.8 Hz, 1H), 5.38 (t, J = 9.9 Hz, 1H), 4.73 (d,
J = 3.5 Hz, 1H), 4.70–4.58 (m, 4H), 4.51–4.43 (m, 1H), 4.21–4.14 (m, 1H), 4.13–4.00 (m, 3H),
3.88–3.78 (m, 1H), 3.02–2.93 (m, 1H), 2.89–2.82 (m, 1H), 2.80–2.70 (m, 2H), 2.66–2.53 (m, 2H)
1.92 (s, 3H), 1.67–1.55 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 170.3, 170.1, 166.8, 165.2, 148.8,
147.9, 133.6, 133.4, 129.8, 129.7, 128.8, 128.7, 128.5, 128.4, 121.6, 120.7, 98.2, 70.9, 69.2, 68.1,
66.9, 62.8, 51.9, 50.3, 45.5, 34.8, 27.7, 24.8, 24.7, 23.2; HRMS m/z calcd for C35H39N7O9Na
[M + Na]+ 724.2701, found 724.2704.
Synthesis of compound 16b (DM25). Compound 15b (68.0 mg, 0.077 mmol), DMF
(12.0 mL), K2CO3 (21.2 mg, 0.15 mmol), 80 ◦C for 2.0 h. Purified by flash chromatography
(DCM to 2% MeOH/DCM) to obtain a white solid (48.0 mg, 88%) as the desired product
(Rf = 0.2 in 5% MeOH/DCM). The reaction was also carried out in acetonitrile: Compound
15b (50.0 mg, 0.05 mmol, 1.0 equiv), CH3CN (10.0 mL), K2CO3 (15.6 mg, 0.11 mmol,
2.0 equiv), 75 ◦C for 14.0 h, yield 28.5 mg, 71%. M.p. 239.0–240.0 ◦C; 1H NMR (400 MHz,
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CDCl3) δ 7.92–7.85 (m, 4H), 7.62 (s, 1H), 7.54–7.47 (m, 2H), 7.46 (s, 1H), 7.39–7.30 (m, 4H),
5.91 (d, J = 9.3 Hz, 1H), 5.56 (t, J = 9.5 Hz, 1H), 5.30 (t, J = 9.9 Hz, 1H), 4.67 (d, J = 3.5 Hz,
1H), 4.65–4.55 (m, 4H), 4.51–4.45 (m, 1H), 4.36–4.30 (m, 1H), 4.16–4.08 (m, 2H), 4.02–3.95
(m, 1H), 3.93–3.87 (m, 1H), 3.03–2.90 (m, 2H), 2.79–2.70 (m, 4H), 1.91 (s, 3H), 1.75–1.66 (m,
4H), 1.32–1.25 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 170.1, 169.9, 166.9, 165.4, 148.2, 147.6,
133.6, 133.5, 129.83, 129.81, 128.8, 128.6, 128.5, 128.4, 122.2, 121.6, 97.9, 71.2, 69.6, 68.6, 66.8,
63.4, 52.0, 49.6, 45.2, 34.3, 27.5, 27.3, 26.1, 24.5, 23.2; HRMS m/z calcd for C36H41N7O9Na
[M + Na]+ 738.2858, found 738.2862.
Synthesis of compound 16c (DM34). Compound 15c (120.0 mg, 0.14 mmol), DMF
(15.0 mL), K2CO3 (37.3 mg, 0.27 mmol), 75 ◦C for 2.0 h. Purified by flash chromatography
(DCM to 3% MeOH/DCM) to obtain a white solid (82.0 mg, 85%) as the desired product,
Rf = 0.21 in 5% MeOH/DCM. The reaction was also carried out in acetonitrile: Compound
15c (50.0 mg, 0.05 mmol, 1.0 equiv), CH3CN (8.0 mL), K2CO3 (15.7 mg, 0.11 mmol, 2.0
equiv), 75 ◦C for 14.0 h, yield 31.5 mg, 78%, m.p. 99.0–101.0 ◦C; 1H NMR (400 MHz, CDCl3)
δ 7.93–7.89 (m, 4H), 7.54–7.47 (m, 2H), 7.39–7.34 (m, 6H), 6.09 (d, J = 8.8 Hz, 1H), 5.54 (t,
J = 10.6 Hz, 1H), 5.46 (t, J = 9.6 Hz, 1H), 4.77 (d, J = 3.7 Hz, 1H), 4.60–4.44 (m, 5H), 4.33–4.26
(m, 1H), 4.17–4.03 (m, 2H), 3.59–3.49 (m, 1H), 3.30–3.21 (m, 1H), 2.83–2.70 (m, 6H), 2.33–2.20
(m, 2H), 1.94 (s, 3H), 1.80–1.69 (m, 2H), 1.69–1.59 (m, 2H); 13C NMR (100 MHz, CDCl3) δ
170.3, 170.1, 167.1, 165.3, 148.2, 147.8, 133.6, 133.5, 129.9, 129.7, 128.8, 128.76, 128.5, 128.4,
121.7, 121.2, 97.7, 71.3, 69.7, 67.7, 64.8, 63.2, 52.4, 46.4, 45.4, 34.8, 29.6, 28.0, 25.1, 24.8, 23.1;
HRMS m/z calcd for C36H41N7O9Na [M + Na]+ 738.2858, found 738.2855.
Synthesis of compound 16d (DM35). Compound 15d (90.0 mg, 0.10 mmol), DMF
(12.0 mL), K2CO3 (27.5 mg, 0.19 mmol), 80 ◦C for 3.0 h. The crude was purified by
flash chromatography (DCM to 3% MeOH/DCM) to obtain a white solid upon standing
(57.0 mg, 78%) as the desired product (Rf = 0.26 in 5% MeOH/DCM). The reaction was
also carried out using CH3CN as the solvent: Compound 15d (50.0 mg, 0.055 mmol),
CH3CN (8.0 mL), K2CO3 (15.3 mg, 0.11 mmol), 75 ◦C for 15.0 h, yield 30.0 mg, 74%. m.p.
92.0–94.0 ◦C; 1H NMR (400 MHz, CDCl3) δ 7.94–7.89 (m, 4H), 7.55–7.46 (m, 2H), 7.42 (s,
1H), 7.41 (s, 1H), 7.38–7.32 (m, 4H), 6.10 (d, J = 9.0 Hz, 1H), 5.57 (t, J = 9.6 Hz, 1H), 5.40 (t,
J = 9.8 Hz, 1H), 4.84 (d, J = 3.7 Hz, 1H), 4.61–4.44 (m, 5H), 4.36–4.28 (m, 1H), 4.25–4.15 (m,
2H), 3.76–3.65 (m, 1H), 3.44–3.33 (m, 1H), 2.99–2.81 (m, 2H), 2.80–2.73 (m, 2H), 2.73–2.67
(m, 2H), 2.36–2.23 (m, 2H), 1.93 (s, 3H), 1.74–1.65 (m, 4H), 1.34–1.27 (m, 2H); 13C NMR
(100 MHz, CDCl3) δ 170.3, 169.8, 167.0, 165.4, 148.3, 147.7, 133.6, 133.5, 129.9, 129.83, 128.80,
128.7, 128.5, 128.4, 122.0, 121.4, 97.6, 71.5, 69.7, 68.4, 65.6, 63.7, 52.3, 46.9, 45.3, 34.5, 29.9,
28.1, 27.8, 26.7, 24.8, 24.8, 23.1; HRMS m/z calcd for C37H43N7O9Na [M + Na]+ 752.3014,
found 752.3011.
Synthesis of compound 18. To a 50 mL RBF, compound 17 (200.0 mg, 0.55 mmol) was
dissolved in HOAc: H2O (v:v 4:1, 5.0 mL) and heated at 75 ◦C for 4 h. The reaction was
stopped, and solvent was dried under vacuum to afford the crude, which was purified by
flash chromatography using eluent from DCM to 3% MeOH/DCM to obtain a colorless
liquid (129 mg, 85%) as the desired product (Rf = 0.3 in 10% MeOH/DCM). 1H NMR
(400 MHz, DMSO-d6) δ 7.97 (d, J = 8.4 Hz, 1H), 4.99 (d, J = 5.6 Hz, 1H), 4.80 (d, J = 5.7 Hz,
1H), 4.56 (d, J = 3.5 Hz, 1H), 4.50 (t, J = 6.0 Hz, 1H), 3.87–3.77 (m, 2H), 3.73–3.61 (m, 2H),
3.52–3.40 (m, 2H), 3.35–3.31 (m, 1H), 3.25 (s, 3H), 3.18–3.10 (m, 1H); 13C NMR (100 MHz,
DMSO-d6) δ 167.5, 97.7, 72.7, 70.73, 70.65, 60.7, 54.2, 53.9, 50.5. LC-MS (ESI+) calcd for
C9H16N4O6 [M + H]+ 277.1, found 277.1.
Synthesis of compound 19. In a 50 mL RBF, compound 18 (500 mg, 1.81 mmol) was
taken and dissolved in pyridine (5.0 mL). To this solution, tosyl chloride (862.7 mg, 4.52
mmol) dissolved in pyridine (5.0 mL) was added dropwise at 0 ◦C. The reaction was
monitored in 1.5 h to see full conversion. Pyridine was dried under vacuum and crude
was coated on silica gel and isolated by flash chromatography using eluent from DCM to
2% MeOH/DCM to obtain a sticky colorless slurry (628 mg, 81%) as the desired product
(Rf = 0.51 in 10% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 8.3 Hz, 2H),
7.34 (d, J = 8.0 Hz, 2H), 6.63 (d, J = 9.0 Hz, 1H), 4.63 (d, J = 3.7 Hz, 1H), 4.36–4.27 (m, 2H),
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4.11–3.99 (m, 3H), 3.78–3.71 (m, 1H), 3.67 (t, J = 9.6 Hz, 1H), 3.49 (t, J = 9.4 Hz, 1H), 3.35 (s,
3H), 3.06 (br s, 2H), 2.44 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 168.3, 145.0, 132.8, 129.9,
128.0, 98.2, 73.4, 70.6, 69.5, 69.0, 55.4, 53.3, 52.4, 21.6. LC-MS (ESI+) calcd for C16H22N4O8S
[M + H]+ 431.1, found 431.1.
Synthesis of compound 20. In a 50 mL RBF, compound 19 (628 mg, 1.46 mmol, 1.0 equiv),
pyridine (3.0 mL) and benzoyl chloride (0.51 mL, 4.38 mmol, 3.0 equiv) was added at
0 ◦C dropwise and let it stir for 1.5 h to see full conversion. The reaction mixture was
extracted with DCM (25.0 mL) and washed with NH4Cl (10.0 mL) and NaHCO3 (10.0 mL)
followed by brine (10.0 mL). The organic layer was then dried over anhydrous Na2SO4
and concentrated under reduced pressure to obtain the crude. Crude was purified by
flash chromatography using eluent from pure hexanes to 40% EtOAc/Hexanes to obtain a
colorless liquid (850 mg, 91%) as the desired product (Rf = 0.35 in 40% EtOAc/Hexanes).
1H NMR (400 MHz, CDCl3) δ 7.91–7.81 (m, 4H), 7.72 (d, J = 8.3 Hz, 2H), 7.55–7.45 (m, 2H),
7.39–7.31 (m, 4H), 7.22 (d, J = 8.0 Hz, 2H), 6.63 (d, J = 9.4 Hz, 1H), 5.56 (dd, J = 10.8, 9.5 Hz,
1H), 5.36 (t, J = 9.6 Hz, 1H), 4.78 (d, J = 3.5 Hz, 1H), 4.50–4.42 (m, 1H), 4.23–4.16 (m, 2H),
4.15–4.09 (m, 1H), 3.85 (d, J = 16.6 Hz, 1H), 3.73 (d, J = 16.6 Hz, 1H), 3.45 (s, 3H), 2.37 (s,
3H); 13C NMR (100 MHz, CDCl3) δ 166.72, 166.69, 165.1, 144.9, 133.52, 133.46, 132.5, 129.9,
129.7, 128.7, 128.6, 128.4, 128.0, 97.9, 71.3, 68.8, 68.11, 68.05, 55.7, 52.5, 52.2, 21.6. LC-MS
(ESI+) calcd for C30H31N4O10S [M + H]+ 639.2, found 639.2.
Synthesis of compound 21. Compound 20 (110.0 mg, 0.17 mmol, 1.0 equiv) in t-BuOH:
THF: H2O (v:v:v 1:1:1, 3.0 mL) and 10-undecynoic acid 10c (40.8 mg, 0.22 mmol, 1.3 equiv),
CuSO4·5H2O (8.6 mg, 0.034 mmol, 0.2 equiv), NaAsc (13.7 mg, 0.069 mmol, 0.4 equiv) and
Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) (18.3 mg, 0.03 mmol, 0.2 equiv)
was added and the reaction mixture was stirred at rt for 7 h. The reaction was stopped,
and solvent was dried under vacuum to afford the crude, which was purified by flash
chromatography using eluent from DCM to 2% MeOH/DCM to obtain white solid (95 mg,
67%) as the desired product (Rf = 0.5 in 5% MeOH/DCM). m.p. 74.5–77.0 ◦C. 1H NMR
(400 MHz, CDCl3) δ 7.89–7.79 (m, 4H), 7.71 (d, J = 8.3 Hz, 2H), 7.54–7.47 (m, 2H), 7.38–7.32
(m, 4H), 7.21 (d, J = 7.9 Hz, 2H), 7.11 (s, 1H), 6.20 (d, J = 9.3 Hz, 1H), 5.54–5.48 (m, 1H),
5.34 (t, J = 9.6 Hz, 1H), 4.91 (d, J = 16.5 Hz, 1H), 4.83 (d, J = 16.5 Hz, 1H), 4.74 (d, J = 3.6
Hz, 1H), 4.49–4.41 (m, 1H), 4.22–4.09 (m, 3H), 3.40 (s, 3H), 2.72–2.61 (m, 2H), 2.36 (s, 3H),
2.33 (t, J = 7.4 Hz, 2H), 1.69–1.54 (m, 4H), 1.36–1.29 (m, 8H); 13C NMR (100 MHz, CDCl3) δ
178.4, 178.1, 166.5, 165.5, 165.0, 149.0, 144.9, 133.5, 132.5, 129.9, 129.8, 128.61, 128.58, 128.5,
128.4, 128.0, 121.9, 97.8, 71.5, 68.7, 68.1, 68.0, 55.8, 52.6, 52.4, 33.91, 33.88, 29.1, 29.01, 28.97,
28.96, 28.93, 28.89, 28.87, 28.6, 28.4, 25.5, 24.71, 24.66, 21.6, 18.4. LC-MS (ESI+) calcd for
C41H49N4O12S [M + H]+ 821.3, found 821.4.
Synthesis of compound 23. Compound 20 (100 mg, 0.16 mmol) was mixed with THF:
H2O: t-BuOH (v:v:v 1:1:1, 3.0 mL). To this solution, 10d (45.0 mg, 0.20 mmol), CuSO4·5H2O
(7.8 mg, 0.031 mmol) and NaAsc (12.4 mg, 0.063 mmol) were added and the reaction
mixture was stirred at rt for 12 h. The reaction was stopped, and solvent was dried under
vacuum, and the crude was purified by flash chromatography using eluent from DCM to
2% DCM/MeOH to obtain a white solid (112 mg, 83%) as the desired product (Rf =0.27 in
5% MeOH/DCM). m.p. 93.5–95.5 ◦C; 1H NMR (400 MHz, CDCl3) δ 7.84–7.77 (m, 4H), 7.70
(d, J = 8.3 Hz, 2H), 7.53–7.44 (m, 3H), 7.37–7.28 (m, 4H), 7.20 (d, J = 8.1 Hz, 2H), 7.14 (br
s, 1H), 6.60 (d, J = 8.7 Hz, 1H), 5.55 (t, J = 10.3 Hz, 1H), 5.37 (t, J = 9.7 Hz, 1H), 4.99–4.84
(m, 2H), 4.77 (d, J = 3.3 Hz, 1H), 4.66–4.57 (m, 2H), 4.49–4.42 (m, 1H), 4.21–4.15 (m, 2H),
4.14–4.08 (m, 1H), 3.39 (s, 3H), 2.92 (t, J = 5.3 Hz, 2H), 2.73 (t, J = 6.0 Hz, 2H), 2.62–2.53 (m,
2H), 2.34 (s, 3H), 1.72–1.47 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 172.4, 166.5, 165.7, 165.0,
148.3, 147.1, 145.0, 133.6, 132.4, 129.81, 129.76, 129.7, 128.6, 128.53, 128.45, 128.4, 128.0, 122.6,
122.3, 97.8, 71.6, 68.6, 68.0, 55.8, 52.5, 52.4, 45.9, 34.9, 28.3, 27.7, 24.9, 24.8, 21.6. LC-MS (ESI+)
calcd for C41H46N7O12S [M + H]+ 860, found 860.
Synthesis of compound 22 (C2ML). Compound 21 (70.0 mg, 0.085 mmol), DMF (14.0 mL)
and K2CO3 (23.5 mg, 0.17 mmol), 75 ◦C, 2 h. Purification by flash chromatography (DCM to
1% MeOH/DCM) to obtain 22 as a white solid (80%, 44 mg). Rf = 0.64 in 5% MeOH/DCM.
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m.p. 207.5–210.0 ◦C. 1H NMR (400 MHz, CDCl3) δ 7.98–7.88 (m, 4H), 7.55–7.48 (m, 3H),
7.41–7.34 (m, 4H), 5.55 (d, J = 9.3 Hz, 1H), 5.42–5.34 (m, 2H), 4.98 (d, J = 16.0 Hz, 1H), 4.80
(d, J = 16.0 Hz, 1H), 4.47–4.27 (m, 4H), 3.91–3.81 (m, 1H), 3.37 (s, 3H), 2.84 (t, J = 6.1 Hz,
2H), 2.29–2.07 (m, 2H), 1.78–1.67 (m, 2H), 1.67–1.49 (m, 2H), 1.39–1.19 (m, 8H); 13C NMR
(100 MHz, CDCl3) δ 173.3, 166.6, 166.0, 165.6, 149.6, 133.5, 129.9, 129.8, 129.7, 129.0, 128.9,
128.5, 128.4, 122.5, 97.8, 72.6, 70.2, 68.7, 62.4, 56.0, 53.7, 53.4, 52.3, 34.2, 31.5, 30.4, 29.9, 29.6,
28.7, 25.4, 25.0. LC-MS (ESI+) calcd for C34H41N4O9 [M + H]+ 649, found 649.
Synthesis of compound 24 (C2DLM). Compound 23 (75.0 mg, 0.087 mmol), K2CO3
(24.1 mg, 0.17 mmol), DMF (10.0 mL), 70 ◦C, 2.0 h. Purification by flash chromatography
(DCM to 2% MeOH/DCM) to obtain a white solid (46 mg, 77%) as the desired product.
Using Na2CO3 as the base: Compound 23 (100.0 mg, 0.12 mmol, 1.0 equiv), Na2CO3
(24.6 mg, 0.23 mmol, 2.0 equiv), DMF (12 mL), 70 ◦C, 2.0 h. The pure compound 24
was obtained in 83% yield, 66 mg. Rf = 0.4 in 5% MeOH/DCM. m.p. 83.5–85.0 ◦C; 1H
NMR (400 MHz, CDCl3) δ7.97–7.87 (m, 4H), 7.57–7.46 (m, 3H), 7.43–7.32 (m, 5H), 5.54 (d,
J = 9.2 Hz, 1H), 5.35–5.28 (m, 1H), 5.24 (t, J = 9.9 Hz, 1H), 4.93 (d, J = 16.2 Hz, 1H), 4.83
(d, J = 16.2 Hz, 1H), 4.67–4.51 (m, 2H), 4.38–4.25 (m, 4H), 3.70–3.62 (m, 1H), 3.01–2.90 (m,
5H), 2.89–2.71 (m, 4H), 2.07–1.92 (m, 2H), 1.83–1.71 (m, 2H); 13C NMR (100 MHz, CDCl3) δ
170.7, 166.5, 165.7, 165.6, 149.2, 147.3, 133.6, 133.4, 129.88, 129.85, 128.9, 128.7, 128.5, 128.4,
122.2, 121.8, 97.4, 72.2, 69.7, 68.3, 63.6, 55.3, 53.4, 52.0, 45.5, 34.8, 29.4, 27.6, 26.1, 25.2. LC-MS
(ESI+) calcd for C34H38N7O9 [M + H]+ 688, found 688.
Synthesis of compound 25 (C2DDL). Compound 23 (100.0 mg, 0.12 mmol), Cs2CO3
(75.8 mg, 0.23 mmol), DMF (12 mL), 70 ◦C, 2.0 h. After solvent was removed, the crude
was purified by flash chromatography (DCM to 5% MeOH/DCM) to obtain the dimeric
macrodilactone compound 25 as a white solid (41 mg, 51 %). Rf = 0.32 in 5% MeOH/DCM).
m.p. 257.0–258.0 ◦C; 1H NMR (400 MHz, CDCl3) δ 8.03–7.97 (m, 4H), 7.96–7.91 (m, 4H),
7.54–7.48 (m, 6H), 7.47 (s, 2H), 7.42–7.33 (m, 8H), 5.31–5.21 (m, 4H), 5.16 (t, J = 9.9 Hz,
2H), 5.09 (d, J = 16.8 Hz, 2H), 4.73–4.64 (m, 4H), 4.56–4.49 (m, 2H), 4.47 (d, J = 4.1 Hz, 2H),
4.38–4.27 (m, 6H), 3.56–3.47 (m, 2H), 3.07 (s, 6H), 2.99–2.92 (m, 4H), 2.88–2.69 (m, 8H),
2.06–1.95 (m, 4H), 1.77–1.68 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 169.9, 166.7, 165.7,
165.4, 149.3, 148.8, 133.5, 133.4, 132.1, 130.0, 129.9, 128.86, 128.85, 128.5, 128.4, 122.8, 97.4,
72.7, 70.0, 68.6, 63.6, 55.5, 53.1, 51.8, 50.4, 33.9, 29.8, 27.1, 26.1, 25.3. LC-MS (ESI+) calcd for
C68H74N14O18Na [M + Na]+ 1398 found 1398.
Synthesis of compound 31 and a general procedure and example in Table 5.
Sugar azide 26 (40.0 mg, 0.11 mmol, 1.0 equiv) and 4-t-butylphenylacetylene (29.0 µL,
0.16 mmol, 1.5 equiv) were dissolved in EtOH:H2O (v 1:1, 2.0 mL), then CuSO4·5H2O
(5.36 mg, 0.021 mmol, 0.2 equiv) and sodium ascorbate (8.51 mg, 0.043 mmol, 0.4 equiv)
were added to the reaction mixture. To this mixture, macrocycle DM25 (3.86, 5.0 mol%)
was added. The reaction was stirred rt for 5.0 h to at which time the starting material was
full converted to product, as indicated by 1H NMR. The reaction was stopped, and solvent
was removed using a rotavap, to obtain the crude, which was further purified with flash
chromatography using eluent of DCM to 1% MeOH/DCM to obtain the desired product
as white solid (54 mg, 95%), Rf = 0.35 in 5% MeOH/DCM. 1H NMR (400 MHz, CDCl3) δ
8.08 (s, 1H), 7.76 (d, J = 8.5 Hz, 2H), 7.44 (d, J = 8.5 Hz, 2H), 6.41 (d, J = 9.1 Hz, 1H), 6.11 (d,
J = 9.9 Hz, 1H), 5.52 (dd, J = 10.3, 9.5 Hz, 1H), 5.26 (t, J = 9.7 Hz, 1H), 4.64 (q, J = 9.8 Hz,
1H), 4.35–4.27 (m, 1H), 4.19–4.12 (m, 1H), 4.05–3.97 (m, 1H), 2.07 (s, 9H), 1.76 (s, 3H), 1.34 (s,
9H); 13C NMR (100 MHz, CDCl3) δ 170.70, 170.66, 170.6, 169.3, 151.8, 148.0, 126.9, 125.9,
125.7, 118.8, 85.9, 75.0, 72.4, 68.0, 61.7, 53.6, 34.7, 31.3, 22.8, 20.7, 20.60, 20.58. LC-MS (ESI+)
calcd for C26H34N4O8Na [M + Na]+ 553 found 553.
4. Conclusions
In summary, we have synthesized several series of novel N-acetyl-D-glucosamine
and triazole-derived macrolactones through intramolecular SN2 reactions in short steps
and high efficiency. The macrocyclization did not require high dilution and was carried
out at about 10 mM concentrations, affording the mono-macrolactones in 76–90% yields.
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Eleven macrolactones cyclized from C1 to C6, and three macrocycles cyclized from C2 to
C6 were synthesized and characterized. The macrocycles showed interesting anion binding
properties with tetrabutylammonium halides. TBACl showed the strongest complexation
with the macrocycles. Moreover, several bistriazole-containing macrolactones also formed
complexes with Cu (II) ions. As indicated by 1H NMR spectra, the amide proton and
triazole signals exhibited significant chemical shift changes, which indicated that the Cu
(II) or anions are binding to the macrolactones in a specific manner and may be useful for
molecular recognition. The applications of these macrocycles as ligands for copper ions for
the cycloaddition reactions of azide and alkynes (AAC) were explored. Interestingly the
bis-triazole-containing macrocycles were highly efficient ligands for accelerating the AAC
reactions significantly, and the monotriazole-based macrolactones were not as effective.
The rate accelerating effects of macrocycles were also selective towards different acetylenes.
The methods of synthesizing these novel sugar-based macrocycles should apply to other
carbohydrate derivatives.
Supplementary Materials: The following are available online. Synthesis of compounds S2-S5, 6c,
6e, 7c and 9; 1H and 13C NMR spectra for all compounds, 2D HSQC and COSY NMR spectra for
compounds 8c, 11a-b, 12a-c, 13a-c, 14a-c, 15a, 16a-d, DLM28, 18, 19, 20, 21, 22, 23, 24, 25 and 31;
anion binding studies for TBAX are included in Figures S1–S22; stacked NMR spectra for copper
complexes are included in Figures S23–S34; screening reactions conditions and stacked NMR spectra
are included on page S97, Tables S1–S8 and Figures S35–S42; FTIR spectra for macrocycles are on
pages S111–S118.
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